UNITED STATESSECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORTPursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report: April 1, 2020(Date of earliest event reported)

Invitae Corporation(Exact name of registrant as specified in its charter)

Delaware 001-36847 27-1701898(State or other jurisdiction of

incorporation or organization) (Commission

File Number) (I.R.S. employer

identification number)

1400 16th Street, San Francisco, California 94103(Address of principal executive offices, including zip code)

(415) 374-7782(Registrant’s telephone number, including area code)

N/A(Former Name or Former Address, if Changed Since Last Report.)

ChecktheappropriateboxbelowiftheForm8-Kfilingisintendedtosimultaneouslysatisfythefilingobligationoftheregistrantunderanyofthefollowingprovisions:

☐ WrittencommunicationspursuanttoRule425undertheSecuritiesAct(17CFR230.425)

☐ SolicitingmaterialpursuanttoRule14a-12undertheExchangeAct(17CFR240.14a-12)

☐ Pre-commencementcommunicationspursuanttoRule14d-2(b)undertheExchangeAct(17CFR240.14d-2(b))

☐ Pre-commencementcommunicationspursuanttoRule13e-4(c)undertheExchangeAct(17CFR240.13e-4(c))

SecuritiesregisteredpursuanttoSection12(b)oftheAct:

Title of each class TradingSymbol

Name of each exchangeon which registered

Common Stock, $0.0001 par value per share NVTA The New York Stock Exchange LLC

IndicatebycheckmarkwhethertheregistrantisanemerginggrowthcompanyasdefinedinRule405oftheSecuritiesActof1933(§230.405ofthischapter)orRule12b-2oftheSecuritiesExchangeActof1934(§240.12b-2ofthischapter).

Emerginggrowthcompany☐

Ifanemerginggrowthcompany,indicatebycheckmarkiftheregistranthaselectednottousetheextendedtransitionperiodforcomplyingwithanyneworrevisedfinancialaccountingstandardsprovidedpursuanttoSection13(a)oftheExchangeAct.☐

Item 8.01 Other Events.

Completion of Acquisitions

OnApril1,2020,InvitaeCorporation(the“Company”)completeditsacquisitionsof(i)YouScriptIncorporated,aprivately-heldDelawarecorporation(“YouScript”),inaccordancewiththetermsofanAgreementandPlanofMerger(the“YouScriptAcquisitionAgreement”),datedasofMarch10,2020,amongtheCompany,YasawaMergerSubAInc.,aDelawarecorporationandwholly-ownedsubsidiaryoftheCompany,YasawaMergerSubBLLC,aDelawarelimitedliabilitycompanyandwholly-ownedsubsidiaryoftheCompany,YouScript,andFortisAdvisorsLLC(asrepresentativeofYouScript’sstockholders),pursuanttowhichtheCompanyacquired100%ofthefullydilutedequityofYouScript(the“YouScriptTransactions”),and(ii)GeneticSolutions,LLC,aPennsylvanialimitedliabilitycompanyoperatingunderthename“Genelex”(“Genelex”),inaccordancewiththetermsofaUnitPurchaseAgreement(the“GenelexAcquisitionAgreement”),datedasofMarch10,2020,amongtheCompany,DavidColaizzi,ChrisHowlett,AnthonyMuhlenkamp,GeraldSchneider,andMattLehrian,pursuanttowhichtheCompanypurchased100%oftheissuedandoutstandingequityofGenelex(the“GenelexTransaction”).

AttheclosingoftheYouScriptTransactions,theCompanyissuedanaggregateof1,832,997sharesofitscommonstock,$0.0001parvaluepershare(“CommonStock”),andpaidapproximately$23.6millionincashtotheformersecurityholdersofYouScript.Uptoanadditional460,455sharesofCommonStockareissuableandapproximately$1.4millionincashispayabletotheformersecurityholdersofYouScript,butsuchamountsaresubjecttoahold-backtosatisfyindemnificationobligationsthatmayariseinconnectionwiththeYouScriptAcquisitionAgreement.InconnectionwiththeYouScriptTransactions,theCompanyenteredintoaRegistrationRightsAgreement(the“YouScriptRegistrationRightsAgreement”)withYouScript’ssecurityholders,pursuanttowhichtheCompanywillregisterforresaleonFormS-3the1,832,997sharesofCommonStockissuedupfronttoYouScript’ssecurityholdersintheYouScriptTransactions.TheYouScriptRegistrationRightsAgreementprovidesthatsuchregistrationrightswillexpireatsuchtimeassuchsharesofCommonStockhavebeendisposedofpursuanttotheresaleregistrationstatementorpursuanttoRule144promulgatedundertheSecuritiesActof1933,orastoanyYouScriptsecurityholderwhenallofsuchYouScriptsecurityholder’ssharesmaybesoldpursuanttoRule144withoutlimitationastomannerofsalerestrictionsorvolumelimitation.

AttheclosingoftheGenelexTransaction,theCompanyissuedanaggregateof808,142sharesofCommonStocktotheformersecurityholdersofGenelex.Upto66,681additionalsharesofCommonStockareissuabletotheformersecurityholdersofGenelex,butaresubjecttoahold-backtosatisfyindemnificationobligationsthatmayariseinconnectionwiththeGenelexAcquisitionAgreement.TheCompanywouldalsobecomeobligatedpursuanttothetermsoftheGenelexAcquisitionAgreementtoissueadditionalsharesofCommonStocktotheformersecurityholdersofGenelexif,withinaspecifiedperiodfollowingtheclosingoftheGenelexTransaction,Genelexachievesacertainproductmilestone,inwhichcasetheCompanywouldthereafterissuetotheformersecurityholdersofGenelexsharesofCommonStockwithavalueequaltoaportionofthegrossrevenuesactuallyreceivedbytheCompanyforthatproductandsimilarproductsduringanearn-outperiodofuptofouryears.InconnectionwiththeGenelexTransaction,theCompanyenteredintoaRegistrationRightsAgreement(the“GenelexRegistrationRightsAgreement”)withGenelex’ssecurityholders,pursuanttowhichtheCompanywillregisterforresaleonFormS-3the808,142sharesofCommonStockissuedupfronttoGenelex’ssecurityholdersintheGenelexTransaction.TheGenelexRegistrationRightsAgreementprovidesthatsuchregistrationrightswillexpireatsuchtimeassuchsharesofCommonStockhavebeendisposedofpursuanttotheresaleregistrationstatementorpursuanttoRule144promulgatedundertheSecuritiesActof1933,orastoanyGenelexsecurityholderwhenallofsuchGenelexsecurityholder’ssharesmaybesoldpursuanttoRule144withoutlimitationastomannerofsalerestrictionsorvolumelimitation.

TheforegoingdescriptionsoftheYouScriptAcquisitionAgreement,theYouScriptRegistrationRightsAgreement,theGenelexAcquisitionAgreement,theGenelexRegistrationRightsAgreementandthetransactionscontemplatedtherebyarenotcompleteandarequalifiedintheirentiretybythefulltextoftheYouScriptAcquisitionAgreement,theYouScriptRegistrationRightsAgreement,theGenelexAcquisitionAgreementandtheGenelexRegistrationRightsAgreement,whichwillbefiledasexhibitstotheCompany’sQuarterlyReportonForm10-QforthequarterendingJune30,2020.

Underwritten Public Offering

OnApril1,2020,theCompanyenteredintoanunderwritingagreement(the“UnderwritingAgreement”)withtheseveralunderwritersnamedintheUnderwritingAgreement(the“Underwriters”)forwhomJ.P.MorganSecurities,LLCandCowenandCompany,LLCareactingasrepresentatives,relatingtothepublicofferingof17,777,778sharesofCommonStockatanofferingpricetothepublicof$9.00pershare.UnderthetermsoftheUnderwritingAgreement,theCompanygrantedtheUnderwritersa30-dayoptiontopurchaseuptoanadditional2,666,666sharesofCommonStock,whichoptionwasexercisedinfull.TheofferingclosedonApril6,2020,resultinginapproximately$172.5millionofnetproceedstotheCompanyafterdeductingunderwritingdiscountsandcommissionsandestimatedofferingexpenses.TheofferingwasmadepursuanttotheCompany’sautomaticshelfregistrationstatementonFormS-3(FileNo.333-230053),thatwasfiledwiththeSecuritiesandExchangeCommissionandbecameautomaticallyeffectiveonMarch4,2019,includingtherelatedprospectus,datedMarch4,2019,assupplementedbytheprospectussupplementdatedApril1,2020.TheUnderwritingAgreementisattachedheretoasExhibit1.1andisincorporatedhereinbyreference.TheforegoingdescriptionofthematerialtermsoftheUnderwritingAgreementdoesnotpurporttobecompleteandisqualifiedinitsentiretybyreferencetothetermsoftheUnderwritingAgreement.AcopyofthelegalopinionrelatingtothelegalityoftheissuanceandsaleofCommonStockintheofferingisattachedheretoasExhibit5.1.

OnApril1,2020,theCompanyissuedapressreleaseannouncingthepricingoftheoffering,andonApril6,2020,theCompanyissuedapressreleaseannouncingtheclosingoftheoffering.CopiesofthepressreleasesareattachedheretoasExhibit99.1andExhibit99.2,respectively,andareincorporatedhereinbyreference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

1.1 UnderwritingAgreementdatedasofApril1,2020amongtheCompanyandJ.P.MorganSecurities,LLCandCowenandCompany,LLC,asrepresentativesoftheseveralunderwriters.

5.1 OpinionofPillsburyWinthropShawPittmanLLP.

23.1 ConsentofPillsburyWinthropShawPittmanLLP(includedinExhibit5.1).

99.1 PressReleasedatedApril1,2020.

99.2 PressReleasedatedApril6,2020.

104 CoverPageInteractiveDataFile(embeddedwithintheInlineXBRLdocument).

SIGNATURE

PursuanttotherequirementsoftheSecuritiesExchangeActof1934,theRegistranthasdulycausedthisreporttobesignedonitsbehalfbytheundersignedhereuntodulyauthorized.

INVITAE CORPORATION

Date:April6,2020 By: /s/ShellyD.Guyer Name: ShellyD.Guyer Title: ChiefFinancialOfficer

Exhibit 1.1

INVITAECORPORATION

17,777,778SharesofCommonStock,$0.0001parvaluepershare

UnderwritingAgreement

April1,2020

J.P.MorganSecuritiesLLCCowenandCompany,LLCAsRepresentativesoftheseveralUnderwriterslistedinSchedule1hereto

c/oJ.P.MorganSecuritiesLLC383MadisonAvenueNewYork,NewYork10179

c/oCowenandCompany,LLC599LexingtonAvenueNewYork,NewYork10022

LadiesandGentlemen:

InvitaeCorporation,aDelawarecorporation(the“Company”),proposestoissueandselltotheseveralunderwriterslistedinSchedule1hereto(the“Underwriters”),forwhomyouareactingasrepresentatives(the“Representatives”),anaggregateof17,777,778sharesofcommonstock,$0.0001parvaluepershare(“CommonStock”),oftheCompany(the“UnderwrittenShares”)and,attheoptionoftheUnderwriters,uptoanadditional2,666,666sharesofcommonstockoftheCompany(the“OptionShares”).TheUnderwrittenSharesandtheOptionSharesarehereinreferredtoasthe“Shares”.ThesharesofcommonstockoftheCompanytobeoutstandingaftergivingeffecttothesaleoftheSharesarereferredtohereinasthe“Stock”.

TheCompanyherebyconfirmsitsagreementwiththeseveralUnderwritersconcerningthepurchaseandsaleoftheShares,asfollows:

1.RegistrationStatement.TheCompanyhaspreparedandfiledwiththeSecuritiesandExchangeCommission(the“Commission”)undertheSecuritiesActof1933,asamended,andtherulesandregulationsoftheCommissionthereunder(collectively,the“SecuritiesAct”),aregistrationstatementonFormS-3ASR(FileNo.333-230053),includingaprospectus,relatingtotheShares.Suchregistrationstatement,asamendedatthetimeitbecameeffective,includingtheinformation,ifany,deemedpursuanttoRule430A,430Bor430CundertheSecuritiesActtobepartoftheregistrationstatementatthetimeofitseffectiveness(“Rule430Information”),isreferredtohereinasthe“RegistrationStatement”;andasusedherein,theterm“PreliminaryProspectus”meanseachprospectusincludedinsuchregistrationstatement(andanyamendmentsthereto)beforeeffectiveness,anyprospectusfiledwiththeCommissionpursuanttoRule424(a)undertheSecuritiesActandtheprospectusincludedintheRegistrationStatementatthetimeofitseffectivenessthatomitsRule430Information,andtheterm“Prospectus”meanstheprospectusintheformfirstused(ormadeavailableuponrequestofpurchaserspursuanttoRule173undertheSecuritiesAct)inconnectionwithconfirmationofsalesoftheShares.IftheCompanyhasfiledanabbreviatedregistrationstatementpursuanttoRule462(b)undertheSecuritiesAct(the“Rule462Registration

1

Statement”),thenanyreferencehereintotheterm“RegistrationStatement”shallbedeemedtoincludesuchRule462RegistrationStatement.Anyreferenceinthisunderwritingagreement(this“Agreement”)totheRegistrationStatement,anyPreliminaryProspectusortheProspectusshallbedeemedtorefertoandincludethedocumentsincorporatedbyreferencethereinpursuanttoItem12ofFormS-3undertheSecuritiesAct,asoftheeffectivedateoftheRegistrationStatementorthedateofsuchPreliminaryProspectusortheProspectus,asthecasemaybe,andanyreferenceto“amend”,“amendment”or“supplement”withrespecttotheRegistrationStatement,anyPreliminaryProspectusortheProspectusshallbedeemedtorefertoandincludeanydocumentsfiledaftersuchdateundertheSecuritiesExchangeActof1934,asamended,andtherulesandregulationsoftheCommissionthereunder(collectively,the“ExchangeAct”)thataredeemedtobeincorporatedbyreferencetherein.CapitalizedtermsusedbutnotdefinedhereinshallhavethemeaningsgiventosuchtermsintheRegistrationStatementandtheProspectus.

AtorpriortotheApplicableTime(asdefinedbelow),theCompanyhadpreparedthefollowinginformation(collectivelywiththepricinginformationsetforthonAnnexA,the“PricingDisclosurePackage”):aPreliminaryProspectusdatedApril1,2020andeach“free-writingprospectus”(asdefinedpursuanttoRule405undertheSecuritiesAct)listedonAnnexAhereto.

“ApplicableTime”means9:00P.M.,NewYorkCitytime,onApril1,2020.

2.PurchaseoftheSharesbytheUnderwriters.

(a)TheCompanyagreestoissueandselltheUnderwrittenSharestotheseveralUnderwritersasprovidedinthisunderwritingagreement(this“Agreement”),andeachUnderwriter,onthebasisoftherepresentations,warrantiesandagreementssetforthhereinandsubjecttotheconditionssetforthherein,agrees,severallyandnotjointly,topurchasefromtheCompanytherespectivenumberofUnderwrittenSharessetforthoppositesuchUnderwriter’snameinSchedule1heretoatapricepershare(the“PurchasePrice”)of$8.46.

Inaddition,theCompanyagreestoissueandselltheOptionSharestotheseveralUnderwritersasprovidedinthisAgreement,andtheUnderwriters,onthebasisoftherepresentations,warrantiesandagreementssetforthhereinandsubjecttotheconditionssetforthherein,shallhavetheoptiontopurchase,severallyandnotjointly,fromtheCompanytheOptionSharesatthePurchasePricelessanamountpershareequaltoanydividendsordistributionsdeclaredbytheCompanyandpayableontheUnderwrittenSharesbutnotpayableontheOptionShares.

IfanyOptionSharesaretobepurchased,thenumberofOptionSharestobepurchasedbyeachUnderwritershallbethenumberofOptionShareswhichbearsthesameratiototheaggregatenumberofOptionSharesbeingpurchasedasthenumberofUnderwrittenSharessetforthoppositethenameofsuchUnderwriterinSchedule1hereto(orsuchnumberincreasedassetforthinSection10hereof)bearstotheaggregatenumberofUnderwrittenSharesbeingpurchasedfromtheCompanybytheseveralUnderwriters,subject,however,tosuchadjustmentstoeliminateanyfractionalSharesastheRepresentativesintheirsolediscretionshallmake.

TheUnderwritersmayexercisetheoptiontopurchaseOptionSharesatanytimeinwhole,orfromtimetotimeinpart,onorbeforethethirtiethdayfollowingthedateoftheProspectus,bywrittennoticefromtheRepresentativestotheCompany.SuchnoticeshallsetforththeaggregatenumberofOptionSharesastowhichtheoptionisbeingexercisedandthedateandtimewhentheOptionSharesaretobedeliveredandpaidfor,whichmaybethesamedateandtimeastheClosingDate(ashereinafterdefined)butshallnotbeearlierthantheClosingDatenorlaterthanthetenthfullbusinessday(ashereinafter

2

defined)afterthedateofsuchnotice(unlesssuchtimeanddatearepostponedinaccordancewiththeprovisionsofSection10hereof).Anysuchnoticeshallbegivenatleasttwobusinessdayspriortothedateandtimeofdeliveryspecifiedtherein.

(b)TheCompanyunderstandsthattheUnderwritersintendtomakeapublicofferingoftheSharesassoonaftertheeffectivenessofthisAgreementasinthejudgmentoftheRepresentativesisadvisable,andinitiallytooffertheSharesonthetermssetforthintheProspectus.TheCompanyacknowledgesandagreesthattheUnderwritersmayofferandsellSharestoorthroughanyaffiliateofanUnderwriter.

(c)PaymentfortheSharesshallbemadebywiretransferinimmediatelyavailablefundstotheaccountspecifiedbytheCompanytotheRepresentativesinthecaseoftheUnderwrittenShares,attheofficesofCooleyLLP,counselfortheUnderwriters,at4401EastgateMall,SanDiego,California92121,at10:00A.M.,NewYorkCitytime,onApril6,2020,oratsuchothertimeorplaceonthesameorsuchotherdate,notlaterthanthefifthbusinessdaythereafter,astheRepresentativesandtheCompanymayagreeuponinwritingor,inthecaseoftheOptionShares,onthedateandatthetimeandplacespecifiedbytheRepresentativesinthewrittennoticeoftheUnderwriters’electiontopurchasesuchOptionShares.ThetimeanddateofsuchpaymentfortheUnderwrittenSharesisreferredtohereinasthe“ClosingDate”,andthetimeanddateforsuchpaymentfortheOptionShares,ifotherthantheClosingDate,ishereinreferredtoasthe“AdditionalClosingDate”.

(d)PaymentfortheSharestobepurchasedontheClosingDateortheAdditionalClosingDate,asthecasemaybe,shallbemadeagainstdeliverytotheRepresentativesfortherespectiveaccountsoftheseveralUnderwritersoftheSharestobepurchasedonsuchdateortheAdditionalClosingDate,asthecasemaybe,withanytransfertaxespayableinconnectionwiththesaleofsuchSharesdulypaidbytheCompany.DeliveryoftheSharesshallbemadethroughthefacilitiesofTheDepositoryTrustCompanyunlesstheRepresentativesshallotherwiseinstruct.

(e)TheCompanyacknowledgesandagreesthattheUnderwritersareactingsolelyinthecapacityofanarm’slengthcontractualcounterpartytotheCompanywithrespecttotheofferingofSharescontemplatedhereby(includinginconnectionwithdeterminingthetermsoftheoffering)andnotasafinancialadvisororafiduciaryto,oranagentof,theCompanyoranyotherperson.Additionally,neithertheRepresentativesnoranyotherUnderwriterisadvisingtheCompanyoranyotherpersonastoanylegal,tax,investment,accountingorregulatorymattersinanyjurisdiction.TheCompanyshallconsultwithitsownadvisorsconcerningsuchmattersandshallberesponsibleformakingitsownindependentinvestigationandappraisalofthetransactionscontemplatedhereby,andtheUnderwritersshallhavenoresponsibilityorliabilitytotheCompanywithrespectthereto.AnyreviewbytheUnderwritersoftheCompany,thetransactionscontemplatedherebyorothermattersrelatingtosuchtransactionswillbeperformedsolelyforthebenefitoftheUnderwritersandshallnotbeonbehalfoftheCompany.

3.RepresentationsandWarrantiesoftheCompany.TheCompanyrepresentsandwarrantstoeachUnderwriterthat:

(a)Preliminary Prospectus.NoorderpreventingorsuspendingtheuseofanyPreliminaryProspectushasbeenissuedbytheCommission,andeachPreliminaryProspectusincludedinthePricingDisclosurePackage,atthetimeoffilingthereof,compliedinallmaterialrespectswiththeSecuritiesAct,andnoPreliminaryProspectus,atthetimeoffilingthereof,containedanyuntruestatementofamaterialfactoromittedtostateamaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,

3

notmisleading;providedthattheCompanymakesnorepresentationorwarrantywithrespecttoanystatementsoromissionsmadeinrelianceuponandinconformitywithinformationrelatingtoanyUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforuseinanyPreliminaryProspectus,itbeingunderstoodandagreedthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsoftheinformationdescribedassuchinSection7(b)hereof.

(b)Pricing Disclosure Package.ThePricingDisclosurePackageasoftheApplicableTimedidnot,andasoftheClosingDateandasoftheAdditionalClosingDate,asthecasemaybe,willnot,containanyuntruestatementofamaterialfactoromittostateamaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,notmisleading;providedthattheCompanymakesnorepresentationandwarrantywithrespecttoanystatementsoromissionsmadeinrelianceuponandinconformitywithinformationrelatingtoanyUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforuseinsuchPricingDisclosurePackage,itbeingunderstoodandagreedthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsoftheinformationdescribedassuchinSection7(b)hereof.NostatementofmaterialfactincludedintheProspectushasbeenomittedfromthePricingDisclosurePackageandnostatementofmaterialfactincludedinthePricingDisclosurePackagethatisrequiredtobeincludedintheProspectushasbeenomittedtherefrom.

(c)Issuer Free Writing Prospectus. OtherthantheRegistrationStatement,thePreliminaryProspectusandtheProspectus,theCompany(includingitsagentsandrepresentatives,otherthantheUnderwritersintheircapacityassuch)hasnotprepared,made,used,authorized,approvedorreferredtoandwillnotprepare,make,use,authorize,approveorrefertoany“writtencommunication”(asdefinedinRule405undertheSecuritiesAct)thatconstitutesanoffertosellorsolicitationofanoffertobuytheShares(eachsuchcommunicationbytheCompanyoritsagentsandrepresentatives(otherthanacommunicationreferredtoinclause(i)below)an“IssuerFreeWritingProspectus”)otherthan(i)anydocumentnotconstitutingaprospectuspursuanttoSection2(a)(10)(a)oftheSecuritiesActorRule134undertheSecuritiesActor(ii)thedocumentslistedonAnnexAhereto,eachelectronicroadshowandanyotherwrittencommunicationsapprovedinwritinginadvancebytheRepresentatives.EachsuchIssuerFreeWritingProspectuscompliedinallmaterialrespectswiththeSecuritiesAct,hasbeenorwillbe(withinthetimeperiodspecifiedinRule433)filedinaccordancewiththeSecuritiesAct(totheextentrequiredthereby)anddoesnotconflictwiththeinformationcontainedintheRegistrationStatementorthePricingDisclosurePackage,and,whentakentogetherwiththePreliminaryProspectusaccompanying,ordeliveredpriortodeliveryof,suchIssuerFreeWritingProspectus,didnot,andasoftheClosingDateandasoftheAdditionalClosingDate,asthecasemaybe,willnot,containanyuntruestatementofamaterialfactoromittostateamaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,notmisleading;providedthattheCompanymakesnorepresentationorwarrantywithrespecttoanystatementsoromissionsmadeineachsuchIssuerFreeWritingProspectusorPreliminaryProspectusinrelianceuponandinconformitywithinformationrelatingtoanyUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforuseinsuchIssuerFreeWritingProspectusorPreliminaryProspectus,itbeingunderstoodandagreedthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsoftheinformationdescribedassuchinSection7(b)hereof.EachsuchIssuerFreeWritingProspectus,asofitsissuedateandatallsubsequenttimesthroughthecompletionofthepublicofferandsaleoftheSharesoruntilanyearlierdatethattheCompanynotifiedornotifiestheRepresentativesasdescribedinSection4(d),didnot,doesnotandwillnotincludeanyinformationthatconflicted,conflictsorwillconflictwiththeinformationcontainedintheRegistrationStatementortheProspectus.

4

(d)[Reserved.]

(e)Testing-the-Waters Communications.TheCompanyhasnotengagedinanyTesting-the-WatersCommunicationsordistributedanyWrittenTesting-the-WatersCommunicationsinconnectionwiththeofferingoftheShares.“WrittenTesting-the-WatersCommunication”meansanyTesting-the-WatersCommunicationthatisawrittencommunicationwithinthemeaningofRule405undertheSecuritiesAct.

(f)Registration Statement and Prospectus.TheRegistrationStatementisan“automaticshelfregistrationstatement”asdefinedunderRule405oftheSecuritiesActthathasbeenfiledwiththeCommissionnotearlierthanthreeyearspriortothedatehereof;andnonoticeofobjectionoftheCommissiontotheuseofsuchregistrationstatementoranypost-effectiveamendmenttheretopursuanttoRule401(g)(2)undertheSecuritiesActhasbeenreceivedbytheCompany.NoordersuspendingtheeffectivenessoftheRegistrationStatementhasbeenissuedbytheCommission,andnoproceedingforthatpurposeorpursuanttoSection8AoftheSecuritiesActagainsttheCompanyorrelatedtotheofferingoftheShareshasbeeninitiatedorthreatenedbytheCommission;asoftheapplicableeffectivedateoftheRegistrationStatementandanypost-effectiveamendmentthereto,theRegistrationStatementandanysuchpost-effectiveamendmentcompliedandwillcomplyinallmaterialrespectswiththeSecuritiesAct,anddidnotandwillnotcontainanyuntruestatementofamaterialfactoromittostateamaterialfactrequiredtobestatedthereinornecessaryinordertomakethestatementsthereinnotmisleading;andasofthedateoftheProspectusandanyamendmentorsupplementtheretoandasoftheClosingDateandasoftheAdditionalClosingDate,asthecasemaybe,theProspectuscompliedandwillcomplyinallmaterialrespectswiththeSecuritiesActandwillnotcontainanyuntruestatementofamaterialfactoromittostateamaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,notmisleading;providedthattheCompanymakesnorepresentationandwarrantywithrespecttoanystatementsoromissionsmadeinrelianceuponandinconformitywithinformationrelatingtoanyUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforuseintheRegistrationStatementandtheProspectusandanyamendmentorsupplementthereto,itbeingunderstoodandagreedthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsoftheinformationdescribedassuchinSection7(b)hereof.

(g)Incorporated Documents.ThedocumentsincorporatedbyreferenceintheRegistrationStatement,theProspectusandthePricingDisclosurePackage,whentheywerefiledwiththeCommissionconformedinallmaterialrespectstotherequirementsoftheExchangeAct,andnoneofsuchdocumentscontainedanyuntruestatementofamaterialfactoromittedtostateamaterialfactnecessarytomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,notmisleading;andanyfurtherdocumentssofiledandincorporatedbyreferenceintheRegistrationStatement,theProspectusorthePricingDisclosurePackage,whensuchdocumentsarefiledwiththeCommission,willconforminallmaterialrespectstotherequirementsoftheExchangeActandwillnotcontainanyuntruestatementofamaterialfactoromittostateamaterialfactnecessarytomakethestatementstherein,inthelightofthecircumstancesunderwhichtheyweremade,notmisleading.

5

(h)Financial Statements.Thefinancialstatements(includingtherelatednotesthereto)oftheCompanyanditsconsolidatedsubsidiariesincludedorincorporatedbyreferenceintheRegistrationStatement,thePricingDisclosurePackageandtheProspectuscomplyinallmaterialrespectswiththeapplicablerequirementsoftheSecuritiesActandtheExchangeAct,asapplicable,andpresentfairly,inallmaterialrespects,thefinancialpositionoftheCompanyanditsconsolidatedsubsidiariesasofthedatesindicatedandtheresultsoftheiroperationsandthechangesintheircashflowsfortheperiodsspecified;suchfinancialstatementshavebeenpreparedinconformitywithgenerallyacceptedaccountingprinciplesintheUnitedStates(“GAAP”)appliedonaconsistentbasisthroughouttheperiodscoveredthereby,andanysupportingschedulesincludedorincorporatedbyreferenceintheRegistrationStatementpresentfairly,inallmaterialrespects,theinformationrequiredtobestatedtherein;andtheotherfinancialinformationincludedorincorporatedbyreferenceintheRegistrationStatement,thePricingDisclosurePackageandtheProspectushasbeenderivedfromtheaccountingrecordsoftheCompanyanditsconsolidatedsubsidiariesandpresentsfairlytheinformationshownthereby.

(i)No Material Adverse Change.SincethedateofthemostrecentfinancialstatementsoftheCompanyincludedorincorporatedbyreferenceintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,(i)therehasnotbeenanychangeinthecapitalstock(otherthantheissuanceofsharesofCommonStockuponexerciseofstockoptionsandwarrantsdescribedasoutstandingin,andthegrantofoptionsandawardsunderexistingequityincentiveplansdescribedin,theRegistrationStatement,thePricingDisclosurePackageandtheProspectus),short-termdebtorlong-termdebtoftheCompanyoranyofitssubsidiaries,oranydividendordistributionofanykinddeclared,setasideforpayment,paidormadebytheCompanyonanyclassofcapitalstock,oranymaterialadversechange,oranydevelopmentthatwouldreasonablybeexpectedtoresultinamaterialadversechange,inoraffectingthebusiness,properties,management,financialposition,stockholders’equity,resultsofoperationsorprospectsoftheCompanyanditssubsidiariestakenasawhole;(ii)neithertheCompanynoranyofitssubsidiarieshasenteredintoanytransactionoragreement(whetherornotintheordinarycourseofbusiness)thatismaterialtotheCompanyanditssubsidiariestakenasawholeorincurredanyliabilityorobligation,directorcontingent,thatismaterialtotheCompanyanditssubsidiariestakenasawhole;and(iii)neithertheCompanynoranyofitssubsidiarieshassustainedanylossorinterferencewithitsbusinessthatismaterialtotheCompanyanditssubsidiariestakenasawholeandthatiseitherfromfire,explosion,floodorothercalamity,whetherornotcoveredbyinsurance,orfromanylabordisturbanceordisputeoranyaction,orderordecreeofanycourtorarbitratororgovernmentalorregulatoryauthority,exceptineachcaseasotherwisedisclosedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus.

(j)Organization and Good Standing.TheCompanyandeachofitssubsidiarieshavebeendulyorganizedandarevalidlyexistingandingoodstandingunderthelawsoftheirrespectivejurisdictionsoforganization,aredulyqualifiedtodobusinessandareingoodstandingineachjurisdictioninwhichtheirrespectiveownershiporleaseofpropertyortheconductoftheirrespectivebusinessesrequiressuchqualification,andhaveallpowerandauthoritynecessarytoownorholdtheirrespectivepropertiesandtoconductthebusinessesinwhichtheyareengaged,exceptwherethefailuretobesoqualifiedoringoodstandingorhavesuchpowerorauthoritywouldnot,individuallyorintheaggregate,haveamaterialadverseeffectonthebusiness,properties,management,financialposition,stockholders’equity,resultsofoperationsorprospectsoftheCompanyanditssubsidiariestakenasawholeorontheperformancebytheCompanyofitsobligationsunderthisAgreement(a“MaterialAdverseEffect”).ExceptasdisclosedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,theCompanydoesnot

6

ownorcontrol,directlyorindirectly,anycorporation,associationorotherentityotherthanthesubsidiarieslistedinExhibit21totheRegistrationStatement.ThesubsidiarieslistedinSchedule2tothisAgreementaretheonlysignificantsubsidiariesoftheCompanyasoftheendoftheCompany’smostrecentlycompletedfiscalyear.

(k)Capitalization.TheCompanyhasanauthorizedcapitalizationassetforthintheRegistrationStatement,thePricingDisclosurePackageandtheProspectusundertheheading“Capitalization”and“Descriptionofcapitalstock”;alltheoutstandingsharesofcapitalstockoftheCompanyhavebeendulyandvalidlyauthorizedandissuedandarefullypaidandnon-assessableandarenotsubjecttoanypre-emptiveorsimilarrights;exceptasdescribedinorexpresslycontemplatedbythePricingDisclosurePackageandtheProspectus,therearenooutstandingrights(including,withoutlimitation,pre-emptiverights),warrantsoroptionstoacquire,orinstrumentsconvertibleintoorexchangeablefor,anysharesofcapitalstockorotherequityinterestintheCompanyoranyofitssubsidiaries,oranycontract,commitment,agreement,understandingorarrangementofanykindrelatingtotheissuanceofanycapitalstockoftheCompanyoranysuchsubsidiary,anysuchconvertibleorexchangeablesecuritiesoranysuchrights,warrantsoroptions;thecapitalstockoftheCompanyconformsinallmaterialrespectstothedescriptionthereofcontainedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus;andalltheoutstandingsharesofcapitalstockorotherequityinterestsofeachsubsidiaryowned,directlyorindirectly,bytheCompanyhavebeendulyandvalidlyauthorizedandissued,arefullypaidandnon-assessable(except,inthecaseofanyforeignsubsidiary,fordirectors’qualifyingshares)andareowneddirectlyorindirectlybytheCompany,freeandclearofanylien,charge,encumbrance,securityinterest,restrictiononvotingortransferoranyotherclaimofanythirdparty.

(l)Stock Options. Withrespecttothestockoptions(the“StockOptions”)grantedpursuanttothestock-basedcompensationplansoftheCompanyanditssubsidiaries(the“CompanyStockPlans”),(i)eachStockOptionintendedtoqualifyasan“incentivestockoption”underSection422oftheInternalRevenueCodeof1986,asamended(the“Code”)soqualifies,(ii)eachgrantofaStockOptionwasdulyauthorizednolaterthanthedateonwhichthegrantofsuchStockOptionwasbyitstermstobeeffectivebyallnecessarycorporateaction,including,asapplicable,approvalbytheboardofdirectorsoftheCompany(oradulyconstitutedandauthorizedcommitteethereof)andanyrequiredstockholderapprovalbythenecessarynumberofvotesorwrittenconsents,andtheawardagreementgoverningsuchgrant(ifany)wasdulyexecutedanddeliveredbyeachpartythereto,(iii)eachsuchgrantwasmadeinaccordancewiththetermsoftheCompanyStockPlansand,totheextentapplicable,theExchangeActandtherulesoftheNewYorkStockExchange(“NYSE”),and(iv)eachsuchgrantwasproperlyaccountedforinaccordancewithGAAPinthefinancialstatements(includingtherelatednotes)oftheCompany.EachCompanyStockPlanisaccuratelydescribedinallmaterialrespectsintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus.

(m)Due Authorization.TheCompanyhasfullright,powerandauthoritytoexecuteanddeliverthisAgreementandtoperformitsobligationshereunder;andallactionrequiredtobetakenforthedueandproperauthorization,executionanddeliverybyitofthisAgreementandtheconsummationbyitofthetransactionscontemplatedherebyhasbeendulyandvalidlytaken.

(n)Underwriting Agreement. ThisAgreementhasbeendulyauthorized,executedanddeliveredbytheCompany.

7

(o)The Shares. TheSharestobeissuedandsoldbytheCompanyhereunderhavebeendulyauthorizedbytheCompanyand,whenissuedanddeliveredandpaidforasprovidedherein,willbedulyandvalidlyissued,willbefullypaidandnonassessableandwillconformtothedescriptionsthereofintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus;andtheissuanceoftheSharesisnotsubjecttoanypreemptiveorsimilarrights;

(p)Description of the Underwriting Agreement.ThisAgreementconformsinallmaterialrespectstothedescriptionthereofcontainedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus.

(q)No Violation or Default.NeithertheCompanynoranyofitssubsidiariesis(i)inviolationofitscharterorby-lawsorsimilarorganizationaldocuments;(ii)indefault,andnoeventhasoccurredthat,withnoticeorlapseoftimeorboth,wouldconstitutesuchadefault,inthedueperformanceorobservanceofanyterm,covenantorconditioncontainedinanyindenture,mortgage,deedoftrust,loanagreementorotheragreementorinstrumenttowhichtheCompanyoranyofitssubsidiariesisapartyorbywhichtheCompanyoranyofitssubsidiariesisboundortowhichanyofthepropertyorassetsoftheCompanyoranyofitssubsidiariesissubject;or(iii)inviolationofanylaworstatuteoranyjudgment,order,ruleorregulationofanycourtorarbitratororgovernmentalorregulatoryauthority,except,inthecaseofclauses(ii)and(iii)above,foranysuchdefaultorviolationthatwouldnot,individuallyorintheaggregate,haveaMaterialAdverseEffect.

(r)No Conflicts. Theexecution,deliveryandperformancebytheCompanyofthisAgreement,theissuanceandsaleoftheSharesandtheconsummationbytheCompanyofthetransactionscontemplatedbythisAgreementwillnot(i)conflictwithorresultinabreachorviolationofanyofthetermsorprovisionsof,orconstituteadefaultunder,orresultinthecreationorimpositionofanylien,chargeorencumbranceuponanypropertyorassetsoftheCompanyoranyofitssubsidiariespursuantto,anyindenture,mortgage,deedoftrust,loanagreementorotheragreementorinstrumenttowhichtheCompanyoranyofitssubsidiariesisapartyorbywhichtheCompanyoranyofitssubsidiariesisboundortowhichanyofthepropertyorassetsoftheCompanyoranyofitssubsidiariesissubject,(ii)resultinanyviolationoftheprovisionsofthecharterorby-lawsorsimilarorganizationaldocumentsoftheCompanyoranyofitssubsidiariesor(iii)resultintheviolationofanylaworstatuteoranyjudgment,order,ruleorregulationofanycourtorarbitratororgovernmentalorregulatoryauthority,except,inthecaseofclauses(i)and(iii)above,foranysuchconflict,breach,violationordefaultthatwouldnot,individuallyorintheaggregate,haveaMaterialAdverseEffect.

(s)No Consents Required.Noconsent,filing,approval,authorization,order,license,registrationorqualificationoforwithanycourtorarbitratororgovernmentalorregulatoryauthorityisrequiredfortheexecution,deliveryandperformancebytheCompanyofthisAgreement,theissuanceandsaleoftheSharesandtheconsummationofthetransactionscontemplatedbythisAgreement,exceptfortheregistrationoftheSharesundertheSecuritiesActandsuchconsents,approvals,authorizations,ordersandregistrationsorqualificationsasmayberequiredbytheFinancialIndustryRegulatoryAuthority,Inc.(“FINRA”)andunderapplicablestatesecuritieslawsinconnectionwiththepurchaseanddistributionoftheSharesbytheUnderwriters.

(t)Legal Proceedings.ExceptasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus:(x)therearenolegal,governmentalorregulatoryinvestigations,actions,suitsorproceedingspendingtowhichtheCompanyoranyofitssubsidiariesisormaybeapartyortowhichanypropertyoftheCompanyoranyofitssubsidiaries

8

isormaybethesubjectthat,individuallyorintheaggregate,ifdeterminedadverselytotheCompanyoranyofitssubsidiaries,couldreasonablybeexpectedtohaveaMaterialAdverseEffectorhaveamaterialadverseeffectonthepowerorabilityoftheCompanytoperformitsobligationsunderthisAgreementortoconsummatethetransactionscontemplatedhereby;(y)totheknowledgeoftheCompany,nosuchinvestigations,actions,suitsorproceedingsarethreatenedorcontemplatedbyanygovernmentalorregulatoryauthorityorthreatenedbyothers;and(z)(i)therearenocurrentorpendinglegal,governmentalorregulatoryactions,suitsorproceedingsthatarerequiredundertheSecuritiesActtobedescribedintheRegistrationStatement,thePricingDisclosurePackageortheProspectusthatarenotsodescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectusand(ii)therearenostatutes,regulationsorcontractsorotherdocumentsthatarerequiredundertheSecuritiesActtobefiledasexhibitstotheRegistrationStatementordescribedintheRegistrationStatement,thePricingDisclosurePackageortheProspectusthatarenotsofiledasexhibitstotheRegistrationStatementordescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus.

(u)Independent Accountants.Ernst&YoungLLP,whohascertifiedcertainfinancialstatementsoftheCompanyanditssubsidiaries,isanindependentregisteredpublicaccountingfirmwithrespecttotheCompanyanditssubsidiarieswithintheapplicablerulesandregulationsadoptedbytheCommissionandthePublicCompanyAccountingOversightBoard(UnitedStates)andasrequiredbytheSecuritiesAct.

(v)Title to Real and Personal Property.TheCompanyanditssubsidiarieshavegoodandmarketabletitleinfeesimple(inthecaseofrealproperty)to,orhavevalidandmarketablerightstoleaseorotherwiseuse,allitemsofrealandpersonalpropertyandassetsthatarematerialtotherespectivebusinessesoftheCompanyanditssubsidiaries,ineachcasefreeandclearofallliens,encumbrances,claimsanddefectsandimperfectionsoftitleexceptthosethat(i)donotmateriallyinterferewiththeusemadeandproposedtobemadeofsuchpropertybytheCompanyanditssubsidiaries,(ii)couldnotreasonablybeexpected,individuallyorintheaggregate,tohaveaMaterialAdverseEffector(iii)resultfromtheleaseofsuchpropertyandassets,totheextentapplicable.

(w)Title to Intellectual Property.ExceptasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus(the“DisclosureDocuments”)orascouldnotreasonablybeexpectedtoresultinaMaterialAdverseEffect,totheCompany’sknowledge(i)theCompanyanditssubsidiariesown,possess,licenseorcanacquireorlicenseonreasonabletermsallmaterialpatents,patentapplications,trademarks,servicemarks,tradenames,trademarkregistrations,servicemarkregistrations,copyrights,licensesandknow-how(includingtradesecretsandotherunpatentedand/orunpatentableproprietaryorconfidentialinformation,systemsorprocedures)necessaryfortheconductoftheirrespectivebusinessesascurrentlyconductedandasproposedtobeconductedinthemannerdescribedintheDisclosureDocuments(collectively,“IntellectualProperty”),and(ii)theconductoftheirrespectivebusinessesdoesnotandwillnotconflictinanymaterialrespectwithanyvalidandenforceableIntellectualPropertyrightsofothers.ExceptasdescribedintheDisclosureDocuments,theCompanyanditssubsidiarieshavenotreceivedanynoticeofanyclaimofinfringement,misappropriationorconflictwithanyintellectualpropertyrightsofanotherinconnectionwithitspatents,patentapplications,patentrights,licenses,inventions,trademarks,servicemarks,tradenames,copyrightsandknow-howwhichcouldreasonablybeexpectedtoresultinaMaterialAdverseEffect,andtheCompanyisunawareofanyfactswhichwouldformareasonablebasisforanysuchnoticeorclaim.TotheCompany’sknowledge,(i)therearenothirdpartyrightstoanyoftheIntellectualPropertythatisdisclosedintheDisclosureDocumentsas

9

ownedbytheCompany(the“CompanyIntellectualProperty”);and(ii)thereisnomaterialinfringementbythirdpartiesofanyoftheCompanyIntellectualProperty.ExceptasdisclosedintheDisclosureDocumentsorascouldnotreasonablybeexpectedtoresultinaMaterialAdverseEffect,thereisnopendingor,totheCompany’sknowledge,threatenedaction,suit,proceedingorclaimbyothers:(A)challengingtheCompany’srightsinortoanyIntellectualProperty,andtheCompanyisunawareofanyfactswhichwouldformareasonablebasisforanysuchaction,suit,proceedingorclaim;(B)challengingthevalidity,enforceabilityorscopeofanyIntellectualProperty,andtheCompanyisunawareofanyfactswhichwouldformareasonablebasisforanysuchaction,suit,proceedingorclaim;or(C)assertingthattheCompanyoritssubsidiariesinfringe,misappropriate,orotherwiseviolate,orwould,uponthecommercializationofanyproductorservicedescribedintheDisclosureDocumentsasunderdevelopment,infringe,misappropriate,orotherwiseviolate,anyintellectualpropertyrightsofothers,andtheCompanyisunawareofanyfactswhichwouldformareasonablebasisforanysuchaction,suit,proceedingorclaim.TotheknowledgeoftheCompany,theCompanyanditssubsidiarieshavecompliedwiththetermsofeachagreementpursuanttowhichIntellectualPropertyhasbeenlicensedtotheCompanyoritssubsidiaries,andallsuchagreementsareinfullforceandeffect.TotheCompany’sknowledge,andexceptasisdisclosedintheDisclosureDocuments,therearenomaterialdefectsinanyofthepatentsorpatentapplicationsincludedintheCompanyIntellectualProperty.

(x)Trade Secrets.TheCompanyanditssubsidiarieshavetakenreasonableandcustomaryactionstoprotecttheirrightsinandpreventtheunauthorizeduseanddisclosureofmaterialtradesecretsandconfidentialbusinessinformation(includingconfidentialsourcecode,ideas,researchanddevelopmentinformation,know-how,formulas,compositions,technicaldata,designs,drawings,specifications,researchrecords,recordsofinventions,testinformation,financial,marketingandbusinessdata,customerandsupplierlistsandinformation,pricingandcostinformation,businessandmarketingplansandproposals)ownedbytheCompanyanditssubsidiaries,and,totheknowledgeoftheCompany,therehasbeennomaterialunauthorizeduseordisclosure.

(y) IT Assets.ExceptascouldnotreasonablybeexpectedtohaveaMaterialAdverseEffect,(i)thecomputers,software,servers,networks,datacommunicationslines,andotherinformationtechnologysystemsowned,licensed,leasedorotherwiseusedbytheCompanyoritssubsidiaries(excludinganypublicnetworks)(collectively,the“ITAssets”)operateandperformasisreasonablynecessaryfortheoperationofthebusinessoftheCompanyanditssubsidiariesascurrentlyconductedandasproposedtobeconductedasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,and(ii)totheCompany’sknowledgesuchITAssetsarenotinfectedbyviruses,disablingcodeorotherharmfulcode.

(z)Data Privacy and Security Laws.TheCompanyanditssubsidiariesare,andatallpriortimeswere,inmaterialcompliancewithallapplicabledataprivacyandsecuritylawsandregulations,includingwithoutlimitationtheHealthInsurancePortabilityandAccountabilityActof1996(“HIPAA”)asamendedbytheHealthInformationTechnologyforEconomicandClinicalHealthAct(the“HITECHAct”)andtheEuropeanUnionGeneralDataProtectionRegulation(“GDPR”)(collectively,the“PrivacyLaws”).ToensurecompliancewiththePrivacyLaws,theCompanyanditssubsidiarieshaveinplace,complywith,andtakeappropriatestepsreasonablydesignedtoensurecomplianceinallmaterialrespectswiththeirpoliciesandproceduresrelatingtodataprivacyandsecurityandthecollection,storage,use,disclosure,handling,andanalysisofPersonalData(the“Policies”).“PersonalData”means(i)anaturalperson’sname,streetaddress,telephonenumber,e-mailaddress,photograph,socialsecuritynumberortaxidentificationnumber,

10

driver’slicensenumber,passportnumber,creditcardnumber,bankinformation,orcustomeroraccountnumber;(ii)anyinformationwhichwouldqualifyas“personallyidentifyinginformation”undertheFederalTradeCommissionAct,asamended;(iii)ProtectedHealthInformationasdefinedbyHIPAA;and(iv)anyinformationthatrelatestoanidentifiedoridentifiablenaturalpersonorotherwiseconstitutespersonallyidentifiableinformation,personalinformation,personaldataorsimilarinformationprotectedbyPrivacyLaws.TheCompanyanditssubsidiarieshaveatalltimesmadeallrequireddisclosurestoandobtainedallnecessaryconsentsfromindividualspursuanttoapplicablelawsandregulatoryrulesorrequirements,andnodisclosuremadepursuanttoanyPolicyhas,totheknowledgeoftheCompany,beeninaccurateorinviolationofanyapplicablelawsandregulatoryrulesorrequirementsinanymaterialrespect.TheCompanyfurthercertifiesthatneitheritnoranysubsidiary:(i)hasreceivednoticeofanyactualorpotentialmaterialliabilityunderorrelatingto,oractualorpotentialmaterialviolationof,anyofthePrivacyLaws,andhasnoknowledgeofanyeventorconditionthatwouldreasonablybeexpectedtoresultinanysuchnotice;(ii)iscurrentlyconductingorpayingfor,inwholeorinpart,anyinvestigation,remediationorothercorrectiveactionpursuanttoanyPrivacyLaw;or(iii)isapartytoanyorder,decree,oragreementthatimposesanyobligationorliabilityunderanyPrivacyLaw.

(aa)No Complaints.Thereisnocomplaint,audit,proceeding,investigation(formalorinformal)orclaimcurrentlypendingagainsttheCompanyoritssubsidiaries,ortotheknowledgeoftheCompany,anyofitscustomers(specifictothecustomer’suseoftheproductsorservicesoftheCompany)bytheFederalTradeCommission,theU.S.DepartmentofHealthandHumanServicesandanyofficecontainedtherein(“HHS”),oranysimilarauthorityinanyjurisdictionotherthantheUnitedStatesoranyothergovernmentalentity,orbyanypersonwithrespecttothecollection,useordisclosureofPersonalDatabytheCompanyoritssubsidiaries,and,totheknowledgeoftheCompany,nosuchcomplaint,audit,proceeding,investigationorclaimisthreatened.

(bb)Clinical Data.Thedescriptionsoftheresultsofanystudiesandtestsconductedbyoronbehalfof,orsponsoredby,theCompanyoritssubsidiaries,orinwhichtheCompanyhasparticipated,thataredescribedintheDisclosurePackageandtheProspectus,ortheresultsofwhicharereferredtointheDisclosurePackageandtheProspectusdonotcontainanymisstatementofmaterialfactoromittostateamaterialfactnecessarytomakesuchstatementsnotmisleading.TheCompanyhasnoknowledgeofanystudiesortestsnotdescribedintheDisclosurePackageandtheProspectustheresultsofwhichreasonablycallintoquestioninanymaterialrespecttheresultsofthestudies,testsandtrialsdescribedintheDisclosurePackageorProspectus.

(cc)Compliance with Health Care Laws.TheCompanyanditssubsidiariesare,andatalltimeshavebeen,incomplianceinallmaterialrespectswithallapplicableHealthCareLaws.ForpurposesofthisAgreement,“HealthCareLaws”means:(i)theFederalFood,Drug,andCosmeticActandtheregulationspromulgatedthereunder;(ii)allapplicablefederal,state,localandforeignhealthcarelaws,including,withoutlimitation,theClinicalLaboratoryImprovementAmendmentsof1988(42U.S.C.Section263aetseq.),theU.S.Anti-KickbackStatute(42U.S.C.Section1320a-7b(b)),theAnti-InducementLaw(42U.S.C.§1320a-7a(a)(5)),theU.S.CivilFalseClaimsAct(31U.S.C.Section3729etseq.),thecriminalFalseStatementsLaw(42U.S.C.Section1320a-7b(a)),18U.S.C.Sections286and287,thehealthcarefraudcriminalprovisionsunderHIPAA(42U.S.C.Section1320detseq.),theStarkLaw(42U.S.C.Section1395nn),thecivilmonetarypenaltieslaw(42U.S.C.Section1320a-7a),theexclusionlaws(42U.S.C.Section1320a-7),lawsgoverninggovernmentfundedorsponsoredhealthcareprograms,andthedirectivesandregulationspromulgatedpursuanttosuchstatutesandanystateornon-U.S.counterpartthereof;(iii)HIPAA,asamendedby

11

theHITECHAct(42U.S.C.Section17921etseq.);(iv)thePatientProtectionandAffordableCareActof2010,asamendedbytheHealthCareandEducationAffordabilityReconciliationActof2010,theregulationspromulgatedthereunder;(v)licensure,quality,safetyandaccreditationrequirementsunderapplicablefederal,state,localorforeignlawsorregulatorybodies;and(vi)allotherlocal,state,federal,national,supranationalandforeignlaws,relatingtotheregulationoftheCompanyoritssubsidiaries.NeithertheCompany,anyofitssubsidiaries,nortotheCompany’sknowledge,anyofitsofficers,directors,employeesoragentshaveengagedinactivitieswhichare,asapplicable,causeformaterialliabilityunderaHealthCareLaw.NeithertheCompanynoranyofitssubsidiarieshasreceivedwrittennoticeofanyclaim,action,suit,proceeding,hearing,enforcement,investigation,arbitrationorotheractionfromanycourtorarbitratororgovernmentalorregulatoryauthorityorthirdpartyallegingamaterialviolationofanyHealthCareLawsnor,totheCompany’sknowledge,isanysuchclaim,action,suit,proceeding,hearing,enforcement,investigation,arbitrationorotheractionthreatened.TheCompanyanditssubsidiarieshavefiled,maintainedorsubmittedallmaterialreports,documents,forms,notices,applications,records,claims,submissionsandsupplementsoramendmentsasrequiredbytheapplicableHealthCareLaws,andallsuchreports,documents,forms,notices,applications,records,claims,submissionsandsupplementsoramendmentswerecompleteandaccurateonthedatefiledinallmaterialrespects(orwerecorrectedorsupplementedbyasubsequentsubmission).NeithertheCompany,anyofitssubsidiaries,noranyoftheirrespectiveemployees,officers,directors,or,totheCompany’sknowledge,agentsisapartytoanycorporateintegrityagreements,monitoringagreements,consentdecrees,settlementorders,orsimilaragreementswithorimposedbyanygovernmentalorregulatoryauthority.Additionally,neithertheCompany,anyofitssubsidiariesnoranyoftheirrespectiveemployees,officers,directors,oragentshasbeenexcluded,suspendedordebarredfromparticipationinanyU.S.federalhealthcareprogramorhumanclinicalresearchor,totheknowledgeoftheCompany,issubjecttoagovernmentalinquiry,investigation,proceeding,orothersimilaractionthatcouldreasonablybeexpectedtoresultindebarment,suspension,orexclusion.

(dd)Clinical Laboratory Tests.TheCompany’sclinicallaboratorytestsareconductedincomplianceinallmaterialrespectswithallapplicableHealthCareLaws,and,totheextentapplicable,therespectivecounterpartsthereofpromulgatedbygovernmentalauthoritiesincountriesoutsidetheUnitedStates.TheCompanyhasnotreceivednoticefromtheFDA,HHSorothergovernmentalauthorityallegingorassertingmaterialnoncompliancewithanyapplicableHealthCareLaw.TotheCompany’sknowledge,neithertheFDAnoranyothergovernmentalauthorityisconsideringsuchaction.

(ee)No Undisclosed Relationships.Norelationship,directorindirect,existsbetweenoramongtheCompanyoranyofitssubsidiaries,ontheonehand,andthedirectors,officersorstockholdersoftheCompanyor,totheknowledgeoftheCompany,thecustomersorsuppliersoftheCompanyoranyofitssubsidiaries,ontheother,thatisrequiredbytheSecuritiesActtobedescribedintheRegistrationStatementandtheProspectusandthatisnotsodescribedinsuchdocumentsandinthePricingDisclosurePackage.

(ff)Investment Company Act.TheCompanyisnotand,aftergivingeffecttotheofferingandsaleoftheSharesandtheapplicationoftheproceedsthereofasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,willnotberequiredtoregisterasan“investmentcompany”oranentity“controlled”byan“investmentcompany”withinthemeaningoftheInvestmentCompanyActof1940,asamended,andtherulesandregulationsoftheCommissionthereunder(collectively,the“InvestmentCompanyAct”).

12

(gg)Taxes.TheCompanyanditssubsidiarieshavepaidallfederal,state,localandforeigntaxesandfiledalltaxreturnsrequiredtobepaidorfiledthroughthedatehereof;andexceptasotherwisedisclosedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,thereisnotaxdeficiencythathasbeen,orcouldreasonablybeexpectedtobe,assertedagainsttheCompanyoranyofitssubsidiariesoranyoftheirrespectivepropertiesorassets.

(hh)Licenses and Permits.TheCompanyanditssubsidiariespossessalllicenses,certificates,permitsandotherauthorizationsissuedby,andhavemadealldeclarationsandfilingswith,theappropriatefederal,state,localorforeigngovernmentalorregulatoryauthoritiesthatarenecessaryfortheownershiporleaseoftheirrespectivepropertiesortheconductoftheirrespectivebusinessesasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,exceptwherethefailuretopossessormakethesamewouldnot,individuallyorintheaggregate,haveaMaterialAdverseEffect;andexceptasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,neithertheCompanynoranyofitssubsidiarieshasreceivednoticeofanyrevocationormodificationofanysuchlicense,certificate,permitorauthorizationorhasanyreasontobelievethatanysuchlicense,certificate,permitorauthorizationwillnotberenewedintheordinarycourse.TotheCompany’sknowledge,nopartygrantinganysuchlicenses,certificates,permitsandotherauthorizationshastakenanyactiontolimit,suspendorrevokethesameinanymaterialrespect.TheCompanyanditssubsidiarieshavefiled,obtained,maintainedorsubmittedallmaterialreports,documents,forms,notices,applications,records,claims,submissionsandsupplementsoramendmentsasrequiredandthatallsuchreports,documents,forms,notices,applications,records,claims,submissionsandsupplementsoramendmentsweremateriallycompleteandcorrectonthedatefiled(orwerecorrectedorsupplementedbyasubsequentsubmission)asrequiredformaintenanceoftheirlicenses,certificates,permitsandotherauthorizationsthatarenecessaryfortheconductoftheirrespectivebusinesses.

(ii)No Labor Disputes.NolabordisturbancebyordisputewithemployeesoftheCompanyoranyofitssubsidiariesexistsor,totheknowledgeoftheCompany,iscontemplatedorthreatened,andtheCompanyisnotawareofanyexistingorimminentlabordisturbanceby,ordisputewith,theemployeesofanyofitsoritssubsidiaries’principalsuppliers,contractorsorcustomers,exceptaswouldnothaveaMaterialAdverseEffect.

(jj)Compliance with and Liability under Environmental Laws.(i)TheCompanyanditssubsidiaries(a)are,andatallpriortimeswere,inmaterialcompliancewithanyandallapplicablefederal,state,localandforeignlaws,rules,regulations,requirements,decisions,judgments,decrees,ordersandthecommonlawrelatingtopollutionortheprotectionoftheenvironment,naturalresourcesorhumanhealthorsafety,includingthoserelatingtothegeneration,storage,treatment,use,handling,transportation,ReleaseorthreatofReleaseofHazardousMaterials(collectively,“EnvironmentalLaws”),(b)havereceivedandareincompliancewithallpermits,licenses,certificatesorotherauthorizationsorapprovalsrequiredofthemunderapplicableEnvironmentalLawstoconducttheirrespectivebusinesses,(c)havenotreceivednoticeofanyactualorpotentialliabilityunderorrelatingto,oractualorpotentialviolationof,anyEnvironmentalLaws,includingfortheinvestigationorremediationofanyReleaseorthreatofReleaseofHazardousMaterials,andhavenoknowledgeofanyeventorconditionthatwouldreasonablybeexpectedtoresultinanysuchnotice,(d)arenotconductingorpayingfor,inwholeorinpart,anyinvestigation,remediationorothercorrectiveactionpursuanttoanyEnvironmentalLawatanylocation,and(e)arenotapartytoanyorder,decreeoragreementthatimposesanyobligationorliabilityunderanyEnvironmentalLaw,and(ii)therearenocostsorliabilities

13

associatedwithEnvironmentalLawsoforrelatingtotheCompanyoritssubsidiaries,exceptinthecaseofeachof(i)and(ii)above,foranysuchmatter,aswouldnot,individuallyorintheaggregate,reasonablybeexpectedtohaveaMaterialAdverseEffect;and(iii)exceptasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,(a)therearenoproceedingsthatarepending,orthatareknowntobecontemplated,againsttheCompanyoranyofitssubsidiariesunderanyEnvironmentalLawsinwhichagovernmentalentityisalsoaparty,otherthansuchproceedingsregardingwhichitisreasonablybelievednomonetarysanctionsof$100,000ormorewillbeimposed,(b)theCompanyanditssubsidiariesarenotawareofanyfactsorissuesregardingtheCompany’soritssubsidiaries’compliancewithEnvironmentalLaws,orliabilitiesorotherobligationsunderEnvironmentalLaws,includingtheReleaseorthreatofReleaseofHazardousMaterials,thatcouldreasonablybeexpectedtohaveamaterialeffectonthecapitalexpenditures,earningsorcompetitivepositionoftheCompanyanditssubsidiaries,and(c)noneoftheCompanyanditssubsidiariesanticipatesmaterialcapitalexpendituresrelatingtoanyEnvironmentalLaws.

(kk)Hazardous Materials.Therehasbeennostorage,generation,transportation,use,handling,treatment,ReleaseorthreatofReleaseofHazardousMaterialsby,relatingtoorcausedbytheCompanyoranyofitssubsidiaries(or,totheknowledgeoftheCompanyanditssubsidiaries,anyotherentity(includinganypredecessor)forwhoseactsoromissionstheCompanyoranyofitssubsidiariesisorcouldreasonablybeexpectedtobeliable)at,on,underorfromanypropertyorfacilitynoworpreviouslyowned,operatedorleasedbytheCompanyoranyofitssubsidiaries,orat,on,underorfromanyotherpropertyorfacility,inviolationofanyEnvironmentalLawsorinamanneroramountortoalocationthatcouldreasonablybeexpectedtoresultinanyliabilityunderanyEnvironmentalLaw,exceptforanyviolationorliabilitywhichwouldnot,individuallyorintheaggregate,reasonablybeexpectedtohaveaMaterialAdverseEffect.“HazardousMaterials”meansanymaterial,chemical,substance,waste,pollutant,contaminant,compound,mixture,orconstituentthereof,inanyformoramount,includingpetroleum(includingcrudeoiloranyfractionthereof)andpetroleumproducts,naturalgasliquids,asbestosandasbestoscontainingmaterials,naturallyoccurringradioactivematerials,brine,anddrillingmud,regulatedorwhichcangiverisetoliabilityunderanyEnvironmentalLaw.“Release”meansanyspilling,leaking,seepage,pumping,pouring,emitting,emptying,discharging,injecting,escaping,leaching,dumping,disposing,depositing,dispersing,ormigratingin,intoorthroughtheenvironment,orin,intofromorthroughanybuildingorstructure.

(ll)Compliance with ERISA.(i)Eachemployeebenefitplan,withinthemeaningofSection3(3)oftheEmployeeRetirementIncomeSecurityActof1974,asamended(“ERISA”),forwhichtheCompanyoranymemberofits“ControlledGroup”(definedasanyorganizationwhichisamemberofacontrolledgroupofcorporationswithinthemeaningofSection414oftheCode)wouldhaveanyliability(each,a“Plan”)hasbeenmaintainedincompliancewithitstermsandtherequirementsofanyapplicablestatutes,orders,rulesandregulations,includingbutnotlimitedtoERISAandtheCode,exceptfornoncompliancethatcouldnotreasonablybeexpectedtoresultinmaterialliabilitytotheCompanyoritssubsidiaries;(ii)noprohibitedtransaction,withinthemeaningofSection406ofERISAorSection4975oftheCode,hasoccurredwithrespecttoanyPlanexcludingtransactionseffectedpursuanttoastatutoryoradministrativeexemptionthatcouldreasonablybeexpectedtoresultinamaterialliabilitytotheCompanyoritssubsidiaries;(iii)foreachPlanthatissubjecttothefundingrulesofSection412oftheCodeorSection302ofERISA,theminimumfundingstandardofSection412oftheCodeorSection302ofERISA,asapplicable,hasbeensatisfied(withouttakingintoaccountanywaiverthereoforextensionofanyamortizationperiod)andisreasonablyexpectedtobesatisfiedinthefuture(withouttakinginto

14

accountanywaiverthereoforextensionofanyamortizationperiod);(iv)thefairmarketvalueoftheassetsofeachPlanexceedsthepresentvalueofallbenefitsaccruedundersuchPlan(determinedbasedonthoseassumptionsusedtofundsuchPlan);(v)no“reportableevent”(withinthemeaningofSection4043(c)ofERISA)hasoccurredorisreasonablyexpectedtooccurthateitherhasresulted,orcouldreasonablybeexpectedtoresult,inmaterialliabilitytotheCompanyoritssubsidiaries;(vi)neithertheCompanynoranymemberoftheControlledGrouphasincurred,norreasonablyexpectstoincur,anyliabilityunderTitleIVofERISA(otherthancontributionstothePlanorpremiumstothePBGC,intheordinarycourseandwithoutdefault)inrespectofaPlan(includinga“multiemployerplan”,withinthemeaningofSection4001(a)(3)ofERISA);and(vii)thereisnopendingauditorinvestigationbytheInternalRevenueService,theU.S.DepartmentofLabor,thePensionBenefitGuarantyCorporationoranyothergovernmentalagencyoranyforeignregulatoryagencywithrespecttoanyPlanthatcouldreasonablybeexpectedtoresultinmaterialliabilitytotheCompanyoritssubsidiaries.Noneofthefollowingeventshasoccurredorisreasonablylikelytooccur:(x)amaterialincreaseintheaggregateamountofcontributionsrequiredtobemadetoallPlansbytheCompanyoritssubsidiariesinthecurrentfiscalyearoftheCompanyanditssubsidiariescomparedtotheamountofsuchcontributionsmadeintheCompanyanditssubsidiaries’mostrecentlycompletedfiscalyear;or(y)amaterialincreaseintheCompanyanditssubsidiaries’“accumulatedpost-retirementbenefitobligations”(withinthemeaningofStatementofFinancialAccountingStandards106)comparedtotheamountofsuchobligationsintheCompanyanditssubsidiaries’mostrecentlycompletedfiscalyear.

(mm)Disclosure Controls.TheCompanyanditssubsidiariesmaintainasystemofdisclosurecontrolsandprocedures(asdefinedinRule13a-15(e)oftheExchangeAct)thatcomplywiththerequirementsoftheExchangeActandthathasbeendesignedtoensurethatinformationrequiredtobedisclosedbytheCompanyinreportsthatitfilesorsubmitsundertheExchangeActisrecorded,processed,summarizedandreportedwithinthetimeperiodsspecifiedintheCommission’srulesandforms,includingcontrolsandproceduresdesignedtoensurethatsuchinformationisaccumulatedandcommunicatedtotheCompany’smanagementasappropriatetoallowtimelydecisionsregardingrequireddisclosure.TheCompanyanditssubsidiarieshavecarriedoutevaluationsoftheeffectivenessoftheirdisclosurecontrolsandproceduresasrequiredbyRule13a-15oftheExchangeAct.

(nn)Accounting Controls.TheCompanyanditssubsidiariesmaintainasystemofinternalcontroloverfinancialreporting(asdefinedinRule13a-15(f)oftheExchangeAct)thatcomplywiththerequirementsoftheExchangeActandhavebeendesignedby,orunderthesupervisionof,theirrespectiveprincipalexecutiveandprincipalfinancialofficers,orpersonsperformingsimilarfunctions,toprovidereasonableassuranceregardingthereliabilityoffinancialreportingandthepreparationoffinancialstatementsforexternalpurposesinaccordancewithGAAP,including,butnotlimitedto,internalaccountingcontrolssufficienttoprovidereasonableassurancethat(i)transactionsareexecutedinaccordancewithmanagement’sgeneralorspecificauthorizations;(ii)transactionsarerecordedasnecessarytopermitpreparationoffinancialstatementsinconformitywithGAAPandtomaintainassetaccountability;(iii)accesstoassetsispermittedonlyinaccordancewithmanagement’sgeneralorspecificauthorization;(iv)therecordedaccountabilityforassetsiscomparedwiththeexistingassetsatreasonableintervalsandappropriateactionistakenwithrespecttoanydifferencesand(v)interactivedataineXtensibleBusinessReportingLanguageincludedorincorporatedbyreferenceintheRegistrationStatementfairlypresentstheinformationcalledforinallmaterialrespectsandispreparedinaccordancewiththeCommission’srulesandguidelinesapplicablethereto.ExceptasdisclosedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus,therearenomaterialweaknessesin

15

theCompany’sinternalcontrolsoverfinancialreporting.TheCompany’sauditorsandtheAuditCommitteeoftheBoardofDirectorsoftheCompanyhavebeenadvisedof:(i)allsignificantdeficienciesandmaterialweaknessesinthedesignandoperationofinternalcontrolsoverfinancialreportingwhichhaveadverselyaffectedorarereasonablylikelytoadverselyaffecttheCompany’sabilitytorecord,process,summarizeandreportfinancialinformation;and(ii)anyfraud,whetherornotmaterial,thatinvolvesmanagementorotheremployeeswhohaveasignificantroleintheCompany’sinternalaccountingcontrolsoverfinancialreporting.

(oo)eXtensible Business Reporting Language.TheinteractivedataineXtensibleBusinessReportingLanguageincludedorincorporatedbyreferenceintheRegistrationStatementfairlypresentstheinformationcalledforinallmaterialrespectsandhasbeenpreparedinaccordancewiththeCommission’srulesandguidelinesapplicablethereto.

(pp)Insurance. TheCompanyanditssubsidiarieshaveinsurancecoveringtheirrespectiveproperties,operations,personnelandbusinesses,includingbusinessinterruptioninsurance,whichinsuranceisinamountsandinsuresagainstsuchlossesandriskstheCompanyreasonablybelievesasareadequatetoprotecttheCompanyanditssubsidiariesandtheirrespectivebusinesses;andneithertheCompanynoranyofitssubsidiarieshas(i)receivednoticefromanyinsureroragentofsuchinsurerthatcapitalimprovementsorotherexpendituresarerequiredornecessarytobemadeinordertocontinuesuchinsuranceor(ii)anyreasontobelievethatitwillnotbeabletorenewitsexistinginsurancecoverageasandwhensuchcoverageexpiresortoobtainsimilarcoverageatreasonablecostfromsimilarinsurersasmaybenecessarytocontinueitsbusiness.

(qq)No Unlawful Payments.NeithertheCompanynoranyofitssubsidiariesnor,totheknowledgeoftheCompany,anydirector,officer,employee,agent,affiliateorotherpersonassociatedwithoractingonbehalfoftheCompanyoranyofitssubsidiarieshas(i)usedanycorporatefundsforanyunlawfulcontribution,gift,entertainmentorotherunlawfulexpenserelatingtopoliticalactivity;(ii)madeortakenanactinfurtheranceofanoffer,promiseorauthorizationofanydirectorindirectunlawfulpaymentorbenefittoanyforeignordomesticgovernmentorregulatoryofficialoremployee,includingofanygovernment-ownedorcontrolledentityorofapublicinternationalorganization,oranypersonactinginanofficialcapacityfororonbehalfofanyoftheforegoing,oranypoliticalpartyorpartyofficialorcandidateforpoliticaloffice;(iii)violatedorisinviolationofanyprovisionoftheForeignCorruptPracticesActof1977,asamended,oranyapplicablelaworregulationimplementingtheOECDConventiononCombatingBriberyofForeignPublicOfficialsinInternationalBusinessTransactions,orcommittedanoffenceundertheBriberyAct2010oftheUnitedKingdom,oranyotherapplicableanti-briberyoranti-corruptionlaws;or(iv)made,offered,agreedortakenanyactinfurtheranceofanybribe,unlawfulrebate,payoff,influencepayment,kickbackorotherunlawfulpaymentorbenefit.TheCompanyanditssubsidiarieshaveinstituted,maintainandenforce,andwillcontinuetomaintainandenforcepoliciesandproceduresdesignedtopromoteandensurecompliancewithallapplicableanti-briberyandanti-corruptionlaws.

(rr)Compliance with Anti-Money Laundering Laws.TheoperationsoftheCompanyanditssubsidiariesareandhavebeenconductedatalltimesincompliancewithapplicablefinancialrecordkeepingandreportingrequirements,includingthoseoftheCurrencyandForeignTransactionsReportingActof1970,asamended,theapplicablemoneylaunderingstatutesofalljurisdictionswheretheCompanyoranyofitssubsidiariesconductsbusiness,therulesandregulationsthereunderandanyrelatedorsimilarrules,regulationsorguidelinesissued,

16

administeredorenforcedbyanygovernmentalorregulatoryagency(collectively,the“Anti-MoneyLaunderingLaws”)andnoaction,suitorproceedingbyorbeforeanycourtorgovernmentalorregulatoryagency,authorityorbodyoranyarbitratorinvolvingtheCompanyoranyofitssubsidiarieswithrespecttotheAnti-MoneyLaunderingLawsispendingor,totheknowledgeoftheCompany,threatened.

(ss)No Conflicts with Sanctions Laws. NeithertheCompanynoranyofitssubsidiaries,nor,totheknowledgeoftheCompany,anyofitsdirectors,officers,employees,agents,affiliatesorotherpersonsassociatedwithoractingonbehalfoftheCompanyoranyofitssubsidiaries,iscurrentlythesubjectorthetargetofanysanctionsadministeredorenforcedbytheU.S.Government,(including,withoutlimitation,theOfficeofForeignAssetsControloftheU.S.DepartmentoftheTreasuryortheU.S.DepartmentofStateandincluding,withoutlimitation,thedesignationasa“speciallydesignatednational”or“blockedperson”),theUnitedNationsSecurityCouncil,theEuropeanUnion,HerMajesty’sTreasury,orotherrelevantsanctionsauthority(collectively,“Sanctions”),noristheCompany,anyofitssubsidiarieslocated,organizedorresidentinacountryorterritorythatisthesubjectorthetargetofSanctions,including,withoutlimitation,Cuba,Iran,NorthKorea,SyriaandCrimea(each,a“SanctionedCountry”);andtheCompanywillnotdirectlyorindirectlyusetheproceedsoftheofferingoftheShareshereunder,orlend,contributeorotherwisemakeavailablesuchproceedstoanysubsidiary,jointventurepartnerorotherpersonorentity(i)tofundorfacilitateanyactivitiesoforbusinesswithanypersonthat,atthetimeofsuchfundingorfacilitation,isthesubjectorthetargetofSanctions,(ii)tofundorfacilitateanyactivitiesoforbusinessinanySanctionedCountryor(iii)inanyothermannerthatwillresultinaviolationbyanyperson(includinganypersonparticipatinginthetransaction,whetherasunderwriter,advisor,investororotherwise)ofSanctions.Forthepastfiveyears,theCompanyanditssubsidiarieshavenotknowinglyengagedinandarenotnowknowinglyengagedinanydealingsortransactionswithanypersonthatatthetimeofthedealingortransactionisorwasthesubjectorthetargetofSanctionsorwithanySanctionedCountry.

(tt)No Restrictions on Subsidiaries.NosubsidiaryoftheCompanyiscurrentlyprohibited,directlyorindirectly,underanyagreementorotherinstrumenttowhichitisapartyorissubject,frompayinganydividendstotheCompany,frommakinganyotherdistributiononsuchsubsidiary’scapitalstock,fromrepayingtotheCompanyanyloansoradvancestosuchsubsidiaryfromtheCompanyorfromtransferringanyofsuchsubsidiary’spropertiesorassetstotheCompanyoranyothersubsidiaryoftheCompany.

(uu)No Broker’s Fees.NeithertheCompanynoranyofitssubsidiariesisapartytoanycontract,agreementorunderstandingwithanyperson(otherthanthisAgreement)thatwouldgiverisetoavalidclaimagainsttheCompanyoranyofitssubsidiariesoranyUnderwriterforabrokeragecommission,finder’sfeeorlikepaymentinconnectionwiththeofferingandsaleoftheShares.

(vv)No Registration Rights.ExceptasdisclosedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectusandashavebeendulywaivedorsatisfied,nopersonhastherighttorequiretheCompanyoranyofitssubsidiariestoregisteranysecuritiesforsaleundertheSecuritiesActbyreasonofthefilingoftheRegistrationStatementwiththeCommissionortheissuanceandsaleoftheShares.

17

(ww)No Stabilization.NeithertheCompanynoranyofitssubsidiariesoraffiliateshastaken,directlyorindirectly,anyactiondesignedtoorthatcouldreasonablybeexpectedtocauseorresultinanystabilizationormanipulationofthepriceoftheShares.

(xx)Margin Rules.TheapplicationoftheproceedsreceivedbytheCompanyfromtheissuance,saleanddeliveryoftheSharesasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectuswillnotviolateRegulationT,UorXoftheBoardofGovernorsoftheFederalReserveSystemoranyotherregulationofsuchBoardofGovernors.

(yy)Forward-Looking Statements.Noforward-lookingstatement(withinthemeaningofSection27AoftheSecuritiesActandSection21EoftheExchangeAct)containedintheRegistrationStatement,thePricingDisclosurePackageortheProspectushasbeenmadewithoutareasonablebasisorhasbeendisclosedotherthaningoodfaith.

(zz)Statistical and Market Data.NothinghascometotheattentionoftheCompanythathascausedtheCompanytobelievethatthestatisticalandmarket-relateddataincludedorincorporatedbyreferenceintheRegistrationStatement,thePricingDisclosurePackageandtheProspectusisnotbasedonorderivedfromsourcesthatarereliableandaccurateinallmaterialrespects.

(aaa)Sarbanes-Oxley Act.ThereisandhasbeennofailureonthepartoftheCompanyor,totheknowledgeoftheCompany,anyoftheCompany’sdirectorsorofficers,intheircapacitiesassuch,tocomplywithanyprovisionoftheSarbanes-OxleyActof2002,asamended,andtherulesandregulationspromulgatedinconnectiontherewith(the“Sarbanes-OxleyAct”)applicabletotheCompanyoranyoftheCompany’sdirectorsorofficers,intheircapacitiesassuch,includingSection402relatedtoloansandSections302and906relatedtocertifications.

(bbb)Status under the Securities Act.AtthetimeoffilingtheRegistrationStatementandanypost-effectiveamendmentthereto,attheearliesttimethereafterthattheCompanyoranyofferingparticipantmadeabona fideoffer(withinthemeaningofRule164(h)(2)undertheSecuritiesAct)oftheSharesandatthedatehereof,theCompanywasnotandisnotan“ineligibleissuer,”asdefinedinRule405undertheSecuritiesAct.TheCompanyhaspaidtheregistrationfeeforthisofferingpursuanttoRule456(b)(1)undertheSecuritiesActorwillpaysuchfeewithinthetimeperiodrequiredbysuchrule(withoutgivingeffecttotheprovisotherein)andinanyeventpriortotheClosingDate.

(ccc)No Ratings.Thereare(andpriortotheClosingDate,willbe)nodebtsecurities,convertiblesecuritiesorpreferredstockissuedorguaranteedbytheCompanyoranyofitssubsidiariesthatareratedbya“nationallyrecognizedstatisticalratingorganization”,assuchtermisdefinedinSection3(a)(62)oftheExchangeAct.

(ddd)Required Filings. TheCompanyhastimelymadeallfilingsrequiredtobemadebyitundertheExchangeAct.

(eee)WKSI.TheCompanyisa“well-knownseasonedissuer”asdefinedinRule405oftheSecuritiesAct.

18

4.FurtherAgreementsoftheCompany.TheCompanycovenantsandagreeswitheachUnderwriterthat:

(a)Required Filings.TheCompanywillfilethefinalProspectuswiththeCommissionwithinthetimeperiodsspecifiedbyRule424(b)andRule430A,430Bor430CundertheSecuritiesAct,willfileanyIssuerFreeWritingProspectustotheextentrequiredbyRule433undertheSecuritiesAct;willfilepromptlyallreportsandanydefinitiveproxyorinformationstatementsrequiredtobefiledbytheCompanywiththeCommissionpursuanttoSection13(a),13(c),14or15(d)oftheExchangeActsubsequenttothedateoftheProspectusandforsolongasthedeliveryofaprospectusisrequiredinconnectionwiththeofferingorsaleoftheShares;andwillfurnishcopiesoftheProspectusandeachIssuerFreeWritingProspectus(totheextentnotpreviouslydelivered)totheUnderwritersinNewYorkCitypriorto10:00A.M.,NewYorkCitytime,onthebusinessdaynextsucceedingthedateofthisAgreementinsuchquantitiesastheRepresentativesmayreasonablyrequest.TheCompanywillpaytheregistrationfeeforthisofferingwithinthetimeperiodrequiredbyRule456(b)(1)undertheSecuritiesAct(withoutgivingeffecttotheprovisotherein)andinanyeventpriortotheClosingDate.

(b)Delivery of Copies.TheCompanywilldeliver,withoutcharge,(i)totheRepresentatives,twosignedcopiesoftheRegistrationStatementasoriginallyfiledandeachamendmentthereto,ineachcaseincludingallexhibitsandconsentsfiledtherewithanddocumentsincorporatedbyreferencetherein;and(ii)toeachUnderwriter(A)aconformedcopyoftheRegistrationStatementasoriginallyfiledandeachamendmentthereto(withoutexhibits)and(B)duringtheProspectusDeliveryPeriod(asdefinedbelow),asmanycopiesoftheProspectus(includingallamendmentsandsupplementstheretoanddocumentsincorporatedbyreferencethereinandeachIssuerFreeWritingProspectus)astheRepresentativesmayreasonablyrequest.Asusedherein,theterm“ProspectusDeliveryPeriod”meanssuchperiodoftimeafterthefirstdateofthepublicofferingoftheSharesasintheopinionofcounselfortheUnderwritersaprospectusrelatingtotheSharesisrequiredbylawtobedelivered(orrequiredtobedeliveredbutforRule172undertheSecuritiesAct)inconnectionwithsalesoftheSharesbyanyUnderwriterordealer.

(c)Amendments or Supplements, Issuer Free Writing Prospectuses.Beforepreparing,using,authorizing,approving,referringtoorfilinganyIssuerFreeWritingProspectus,andbeforefilinganyamendmentorsupplementtotheRegistrationStatementortheProspectus,theCompanywillfurnishtotheRepresentativesandcounselfortheUnderwritersacopyoftheproposedIssuerFreeWritingProspectus,amendmentorsupplementforreviewandwillnotprepare,use,authorize,approve,refertoorfileanysuchIssuerFreeWritingProspectusorfileanysuchproposedamendmentorsupplementtowhichtheRepresentativesreasonablyobject.

(d)Notice to the Representatives.TheCompanywilladvisetheRepresentativespromptly,andconfirmsuchadviceinwriting,(i)whenanyamendmenttotheRegistrationStatementhasbeenfiledorbecomeseffective;(ii)whenanysupplementtotheProspectus,anyIssuerFreeWritingProspectus,oranyamendmenttotheProspectushasbeenfiledordistributed;(iii)ofanyrequestbytheCommissionforanyamendmenttotheRegistrationStatementoranyamendmentorsupplementtotheProspectusorthereceiptofanycommentsfromtheCommissionrelatingtotheRegistrationStatementoranyotherrequestbytheCommissionforanyadditionalinformationincluding,butnotlimitedto,anyrequestforinformationconcerninganyTesting-the-WatersCommunication;(iv)oftheissuancebytheCommissionofanyordersuspendingtheeffectivenessoftheRegistrationStatementorpreventingorsuspendingtheuseofanyPreliminaryProspectus,anyofthePricingDisclosurePackage,ortheProspectusortheinitiationorthreateningofanyproceedingforthatpurposeorpursuanttoSection8AoftheSecuritiesAct;(v)oftheoccurrenceofanyeventordevelopmentwithintheProspectusDeliveryPeriodasaresultofwhich

19

theProspectus,thePricingDisclosurePackageoranyIssuerFreeWritingProspectusasthenamendedorsupplementedwouldincludeanyuntruestatementofamaterialfactoromittostateamaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesexistingwhentheProspectus,thePricingDisclosurePackage,oranysuchIssuerFreeWritingProspectusisdeliveredtoapurchaser,notmisleading;(vi)ofthereceiptbytheCompanyofanynoticeofobjectionoftheCommissiontotheuseoftheRegistrationStatementoranypost-effectiveamendmenttheretopursuanttoRule401(g)(2)undertheSecuritiesAct;and(vii)ofthereceiptbytheCompanyofanynoticewithrespecttoanysuspensionofthequalificationoftheSharesforofferandsaleinanyjurisdictionortheinitiationorthreateningofanyproceedingforsuchpurpose;andtheCompanywilluseitsreasonablebesteffortstopreventtheissuanceofanysuchordersuspendingtheeffectivenessoftheRegistrationStatement,preventingorsuspendingtheuseofanyPreliminaryProspectus,anyofthePricingDisclosurePackageortheProspectusorsuspendinganysuchqualificationoftheSharesand,ifanysuchorderisissued,willobtainassoonaspossiblethewithdrawalthereof.

(e)Ongoing Compliance.(1)IfduringtheProspectusDeliveryPeriod(i)anyeventordevelopmentshalloccurorconditionshallexistasaresultofwhichtheProspectusasthenamendedorsupplementedwouldincludeanyuntruestatementofamaterialfactoromittostateanymaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesexistingwhentheProspectusisdeliveredtoapurchaser,notmisleadingor(ii)itisnecessarytoamendorsupplementtheProspectustocomplywithlaw,theCompanywillimmediatelynotifytheUnderwritersthereofandforthwithprepareand,subjecttoparagraph(c)above,filewiththeCommissionandfurnishtotheUnderwritersandtosuchdealersastheRepresentativesmaydesignatesuchamendmentsorsupplementstotheProspectus(oranydocumenttobefiledwiththeCommissionandincorporatedbyreferencetherein)asmaybenecessarysothatthestatementsintheProspectusassoamendedorsupplemented(oranydocumenttobefiledwiththeCommissionandincorporatedbyreferencetherein)willnot,inthelightofthecircumstancesexistingwhentheProspectusisdeliveredtoapurchaser,bemisleadingorsothattheProspectuswillcomplywithlawand(2)ifatanytimepriortotheClosingDate(i)anyeventordevelopmentshalloccurorconditionshallexistasaresultofwhichthePricingDisclosurePackageasthenamendedorsupplementedwouldincludeanyuntruestatementofamaterialfactoromittostateanymaterialfactnecessaryinordertomakethestatementstherein,inthelightofthecircumstancesexistingwhenthePricingDisclosurePackageisdeliveredtoapurchaser,notmisleadingor(ii)itisnecessarytoamendorsupplementthePricingDisclosurePackagetocomplywithlaw,theCompanywillimmediatelynotifytheUnderwritersthereofandforthwithprepareand,subjecttoparagraph(c)above,filewiththeCommission(totheextentrequired)andfurnishtotheUnderwritersandtosuchdealersastheRepresentativesmaydesignatesuchamendmentsorsupplementstothePricingDisclosurePackage(oranydocumenttobefiledwiththeCommissionandincorporatedbyreferencetherein)asmaybenecessarysothatthestatementsinthePricingDisclosurePackageassoamendedorsupplementedwillnot,inthelightofthecircumstancesexistingwhenthePricingDisclosurePackageisdeliveredtoapurchaser,bemisleadingorsothatthePricingDisclosurePackagewillcomplywithlaw.

(f)Blue Sky Compliance.TheCompanywillqualifytheSharesforofferandsaleunder(orobtainexemptionsfromtheapplicationof)thesecuritiesorBlueSkylawsofsuchjurisdictionsastheRepresentativesshallreasonablyrequestandwillcontinuesuchqualificationsorexemptionsineffectsolongasrequiredfordistributionoftheShares;providedthattheCompanyshallnotberequiredto(i)qualifyasaforeigncorporationorotherentityorasadealerinsecuritiesinanysuchjurisdictionwhereitwouldnototherwiseberequiredtosoqualify,(ii)fileanygeneralconsenttoserviceofprocessinanysuchjurisdictionor(iii)subjectitselftotaxationinanysuchjurisdictionifitisnototherwisesosubject.

20

(g)Earnings Statement. TheCompanywillmakegenerallyavailabletoitssecurityholdersandtheRepresentativesassoonaspracticableanearningsstatementthatsatisfiestheprovisionsofSection11(a)oftheSecuritiesActandRule158oftheCommissionpromulgatedthereundercoveringaperiodofatleasttwelvemonthsbeginningwiththefirstfiscalquarteroftheCompanyoccurringafterthe“effectivedate”(asdefinedinRule158)oftheRegistrationStatement.

(h)Clear Market.Foraperiodof60daysafterthedateoftheProspectus(the“RestrictedPeriod”),theCompanywillnot(i)offer,pledge,sell,contracttosell,sellanyoptionorcontracttopurchase,purchaseanyoptionorcontracttosell,grantanyoption,rightorwarranttopurchase,orotherwisetransferordisposeof,directlyorindirectly,orfileorsubmitwiththeCommissionaregistrationstatementundertheSecuritiesActrelatingto,anysharesofStockoranysecuritiesconvertibleintoorexercisableorexchangeableforStock,orpubliclydisclosetheintentiontomakeanyoffer,sale,pledge,dispositionorfiling,or(ii)enterintoanyswaporotheragreementthattransfers,inwholeorinpart,anyoftheeconomicconsequencesofownershipoftheStockoranysuchothersecurities,whetheranysuchtransactiondescribedinclause(i)or(ii)aboveistobesettledbydeliveryofStockorsuchothersecurities,incashorotherwise,withoutthepriorwrittenconsentofJ.P.MorganSecuritiesLLC,otherthan(1)theSharestobesoldhereunder,(2)anySharesissuedupontheexerciseofoptionsandthesettlementofrestrictedstockawardsgrantedunderCompanyStockPlans,pursuanttotheconversion,exerciseorexchangeofconvertible,exercisableorexchangeablesecuritiesorpursuanttothepaymentofanydeferredportionofpurchasepricefortheacquisitionofanysubsidiaryoftheCompanyorthereleasefromanescrowassociatedwithsuchanacquisition,ineachcaseoutstandingonthedatehereofandasdescribedintheRegistrationStatement,PricingDisclosurePackageortheProspectus,providednopublicannouncementshallberequiredorshallbemadevoluntarilyduringtheRestrictedPeriodinconnectionwiththetransactionsinthisclause(2),(3)thegrantbytheCompanyofstockoptions,restrictedstockorotherequity-basedcompensationawards(ortheissuanceofSharesuponexerciseorsettlementthereof)toeligibleparticipantspursuanttoemployeebenefitorequityincentiveplansoftheCompanydescribedintheRegistrationStatement,PricingDisclosurePackageandProspectus;providedthat,priortothegrantofanysuchstockoptions,restrictedstockorotherequity-basedawardstoanyexecutiveofficerordirectorpursuanttothisclause(3)thatvestwithinsuch60-dayperiod,eachsuchrecipientofsuchgrantshallhavesignedanddeliveredalock-uplettersubstantiallyintheformattachedheretoasExhibitA,(4)sharesofStockorothersecuritiesissuedinconnectionwithatransactionwithanunaffiliatedthirdpartythatincludesabonafidecommercialrelationship(includingjointventures,marketingordistributionarrangements,collaborationagreementsorlicensingagreements)oranyacquisitionofassetsof,oranyacquisitionofnotlessthanamajorityoracontrollingportionoftheequityof,anotherentity,providedthat(x)theaggregatenumberofsharesissuedduringtheRestrictedPeriodpursuanttothisclause(4)shallnotexceedmorethantenpercent(10%)ofthetotalnumberofoutstandingsharesofStockimmediatelyfollowingtheissuanceandsaleoftheUnderwrittenSharespursuanttothisAgreementand,(y)exceptwithrespecttotheacquisitionsbytheCompanyannouncedpriortothedateofthisAgreement,therecipientsofsuchsharesofStockorsecuritiesissuedpursuanttothisclause(4)duringtheRestrictedPeriodshallenterintoanagreementsubstantiallyintheformofExhibitAheretoorareotherwiserestrictedintradingbysecuritieslawsduringtheRestrictedPeriod,(5)thefilingofresaleregistrationstatementsonFormS-3oranysuccessorformtheretoinrespectofthesecuritiesregisteredpursuanttotheforegoingclause(4),providedthat(x)theaggregatenumber

21

ofsharesregisteredpursuanttotheseresaleregistrationstatementsshallnotexceed3,000,000sharesofCommonStock,and(y)suchresaleregistrationstatementsrelatetoacquisitionsannouncedbytheCompanypriortothedateofthisAgreement,and(6)thefilingofaregistrationstatementonFormS-8oranysuccessorformtheretowithrespecttotheregistrationofsecuritiestobeofferedtotheCompany’s“employees”(asthattermisusedinFormS-8)underanyemployeebenefitorequityincentiveplansoftheCompanydescribedintheRegistrationStatement,PricingDisclosurePackageandProspectus.

(i)Use of Proceeds.TheCompanywillapplythenetproceedsfromthesaleoftheSharesasdescribedintheRegistrationStatement,thePricingDisclosurePackageandtheProspectusundertheheading“Useofproceeds”.

(j)No Stabilization.NeithertheCompanynoritssubsidiariesoraffiliateswilltake,directlyorindirectly,anyactiondesignedtoorthatcouldreasonablybeexpectedtocauseorresultinanystabilizationormanipulationofthepriceoftheStock.

(k)Listing.TheCompanywilluseitsbesteffortstolist,subjecttonoticeofissuance,theSharesontheNYSE.

(l)Reports.SolongastheSharesareoutstanding,theCompanywillfurnishtotheRepresentatives,promptlyfollowingavailability,copiesofallreportsorothercommunications(financialorother)furnishedtoholdersoftheShares,andcopiesofanyreportsandfinancialstatementsfurnishedtoorfiledwiththeCommissionoranynationalsecuritiesexchangeorautomaticquotationsystem;providedtheCompanywillbedeemedtohavefurnishedsuchreportsandfinancialstatementstotheRepresentativestotheextenttheyarefiledontheCommission’sElectronicDataGathering,Analysis,andRetrievalsystem.

(m)Record Retention.TheCompanywill,pursuanttoreasonableproceduresdevelopedingoodfaith,retaincopiesofeachIssuerFreeWritingProspectusthatisnotfiledwiththeCommissioninaccordancewithRule433undertheSecuritiesAct.

(n)Filings.TheCompanywillfilewiththeCommissionsuchreportsasmayberequiredbyRule463undertheSecuritiesAct.

5.CertainAgreementsoftheUnderwriters.EachUnderwriterherebyrepresentsandagreesthat:

(a)Ithasnotused,authorizeduseof,referredtoorparticipatedintheplanningforuseof,andwillnotuse,authorizeuseof,refertoorparticipateintheplanningforuseof,any“freewritingprospectus”,asdefinedinRule405undertheSecuritiesAct(whichtermincludesuseofanywritteninformationfurnishedtotheCommissionbytheCompanyandnotincorporatedbyreferenceintotheRegistrationStatementandanypressreleaseissuedbytheCompany)otherthan(i)afreewritingprospectusthatcontainsno“issuerinformation”(asdefinedinRule433(h)(2)undertheSecuritiesAct)thatwasnotincluded(includingthroughincorporationbyreference)inthePreliminaryProspectusorapreviouslyfiledIssuerFreeWritingProspectus,(ii)anyIssuerFreeWritingProspectuslistedonAnnexAorpreparedpursuanttoSection3(c)orSection4(c)above(includinganyelectronicroadshow),or(iii)anyfreewritingprospectuspreparedbysuchUnderwriterandapprovedbytheCompanyinadvanceinwriting.

22

(b)Ithasnotandwillnot,withoutthepriorwrittenconsentoftheCompany,useanyfreewritingprospectusthatcontainsthefinaltermsoftheSharesunlesssuchtermshavepreviouslybeenincludedinafreewritingprospectusfiledwiththeCommission;providedthatUnderwritersmayuseatermsheetsubstantiallyintheformofAnnexBheretowithouttheconsentoftheCompany;provided furtherthatanyUnderwriterusingsuchtermsheetshallnotifytheCompany,andprovideacopyofsuchtermsheettotheCompany,priorto,orsubstantiallyconcurrentlywith,thefirstuseofsuchtermsheet.

(c)ItisnotsubjecttoanypendingproceedingunderSection8AoftheSecuritiesActwithrespecttotheoffering(andwillpromptlynotifytheCompanyifanysuchproceedingagainstitisinitiatedduringtheProspectusDeliveryPeriod).

6.ConditionsofUnderwriters’Obligations.TheobligationofeachUnderwritertopurchasetheUnderwrittenSharesontheClosingDateortheOptionSharesontheAdditionalClosingDate,asthecasemaybe,asprovidedhereinissubjecttotheperformancebytheCompanyofitscovenantsandotherobligationshereunderandtothefollowingadditionalconditions:

(a)Registration Compliance; No Stop Order.NoordersuspendingtheeffectivenessoftheRegistrationStatementshallbeineffect,andnoproceedingforsuchpurpose,pursuanttoRule401(g)(2)orpursuanttoSection8AundertheSecuritiesActshallbependingbeforeorthreatenedbytheCommission;theProspectusandeachIssuerFreeWritingProspectusshallhavebeentimelyfiledwiththeCommissionundertheSecuritiesAct(inthecaseofanIssuerFreeWritingProspectus,totheextentrequiredbyRule433undertheSecuritiesAct)andinaccordancewithSection4(a)hereof;andallrequestsbytheCommissionforadditionalinformationshallhavebeencompliedwithtothereasonablesatisfactionoftheRepresentatives.

(b)Representations and Warranties.TherepresentationsandwarrantiesoftheCompanycontainedhereinshallbetrueandcorrectonthedatehereofandonandasoftheClosingDateortheAdditionalClosingDate,asthecasemaybe;andthestatementsoftheCompanyanditsofficersmadeinanycertificatesdeliveredpursuanttothisAgreementshallbetrueandcorrectinallmaterialrespectsonandasoftheClosingDateortheAdditionalClosingDate,asthecasemaybe.

(c)No Downgrade.Subsequenttotheearlierof(A)theApplicableTimeand(B)theexecutionanddeliveryofthisAgreement,ifthereareanydebtsecurities,convertiblesecuritiesorpreferredstockof,orguaranteedby,theCompanyoranyofitssubsidiariesthatareratedbya“nationallyrecognizedstatisticalratingorganization,”assuchtermisdefinedinSection3(a)(62)oftheExchangeAct,(i)nodowngradingshallhaveoccurredintheratingaccordedanysuchdebtsecurities,convertiblesecuritiesorpreferredstockand(ii)nosuchorganizationshallhavepubliclyannouncedthatithasundersurveillanceorreview,orhaschangeditsoutlookwithrespectto,itsratingofanysuchdebtsecurities,convertiblesecuritiesorpreferredstock(otherthananannouncementwithpositiveimplicationsofapossibleupgrading).

(d)No Material Adverse Change.NoeventorconditionofatypedescribedinSection3(i)hereofshallhaveoccurredorshallexist,whicheventorconditionisnotdescribedinthePricingDisclosurePackage(excludinganyamendmentorsupplementthereto)andtheProspectus(excludinganyamendmentorsupplementthereto)andtheeffectofwhichinthejudgmentoftheRepresentativesmakesitimpracticableorinadvisabletoproceedwiththeoffering,saleordeliveryoftheSharesontheClosingDateortheAdditionalClosingDate,asthecasemaybe,onthetermsandinthemannercontemplatedbythisAgreement,thePricingDisclosurePackageandtheProspectus.

23

(e)Officers’ Certificate.TheRepresentativesshallhavereceivedonandasoftheClosingDateortheAdditionalClosingDate,asthecasemaybe,acertificateoftwoofthechieffinancialofficer,thechiefaccountingofficerandthechiefexecutiveofficeroftheCompany(i)confirmingthatsuchofficershavecarefullyreviewedtheRegistrationStatement,thePricingDisclosurePackageandtheProspectusand,totheknowledgeofsuchofficers,therepresentationssetforthinSections3(b)and3(d)hereofaretrueandcorrect,(ii)confirmingthattheotherrepresentationsandwarrantiesoftheCompanyinthisAgreementaretrueandcorrectandthattheCompanyhascompliedinallmaterialrespectswithallagreementsandsatisfiedallconditionsonitsparttobeperformedorsatisfiedhereunderatorpriortotheClosingDateortheAdditionalClosingDate,asthecasemaybe,and(iii)totheeffectsetforthinparagraphs(a),(b),(c)and(d)above.

(f)Comfort Letter.OnthedateofthisAgreementandontheClosingDateortheAdditionalClosingDate,asthecasemaybe,Ernst&YoungLLPshallhavefurnishedtotheRepresentatives,attherequestoftheCompany,aletter,datedthedateofdeliverythereofandaddressedtotheUnderwriters,informandsubstancereasonablysatisfactorytotheRepresentatives,containingstatementsandinformationofthetypecustomarilyincludedinaccountants’“comfortletters”tounderwriterswithrespecttothefinancialstatementsandcertainfinancialinformationcontainedinorincorporatedbyreferenceintheRegistrationStatement,thePricingDisclosurePackageandtheProspectus;provided,thattheletterdeliveredontheClosingDateortheAdditionalClosingDate,asthecasemaybe,shallusea“cut-off”datenomorethanthreebusinessdayspriortosuchClosingDateorsuchAdditionalClosingDate,asthecasemaybe.

(g)Opinion, including Negative Assurances, of Counsel for the Company.PillsburyWinthropShawPittmanLLP,counselfortheCompany,shallhavefurnishedtotheRepresentatives,attherequestoftheCompany,theirwrittenopinion,includingnegativeassurances,datedtheClosingDateortheAdditionalClosingDate,asthecasemaybe,andaddressedtotheUnderwriters,informandsubstancereasonablysatisfactorytotheRepresentatives.

(h)Opinion of Intellectual Property Counsel for the Company.PillsburyWinthropShawPittmanLLP,intellectualpropertycounselfortheCompany,shallhavefurnishedtotheRepresentatives,attherequestoftheCompany,theirwrittenopinion,datedtheClosingDateortheAdditionalClosingDate,asthecasemaybe,andaddressedtotheUnderwriters,informandsubstancereasonablysatisfactorytotheRepresentatives.

(i)Opinion of Regulatory Counsel for the Company.McDermottWill&EmeryLLP,regulatorycounselfortheCompany,shallhavefurnishedtotheRepresentatives,attherequestoftheCompany,theirwrittenopinion,datedtheClosingDateortheAdditionalClosingDate,asthecasemaybe,andaddressedtotheUnderwriters,informandsubstancereasonablysatisfactorytotheRepresentatives.

(j)Opinion and Negative Assurance Letter of Counsel for the Underwriters.TheRepresentativesshallhavereceivedonandasoftheClosingDateortheAdditionalClosingDate,asthecasemaybe,anopinionandnegativeassuranceletterofCooleyLLP,counselforthe

24

Underwriters,withrespecttosuchmattersastheRepresentativesmayreasonablyrequest,andsuchcounselshallhavereceivedsuchdocumentsandinformationastheymayreasonablyrequesttoenablethemtopassuponsuchmatters.

(k)No Legal Impediment to Issuance.Noactionshallhavebeentakenandnostatute,rule,regulationorordershallhavebeenenacted,adoptedorissuedbyanyfederal,stateorforeigngovernmentalorregulatoryauthoritythatwould,asoftheClosingDateortheAdditionalClosingDate,asthecasemaybe,preventtheissuanceorsaleoftheSharesbytheCompany;andnoinjunctionororderofanyfederal,stateorforeigncourtshallhavebeenissuedthatwould,asoftheClosingDateortheAdditionalClosingDate,asthecasemaybe,preventtheissuanceorsaleoftheSharesbytheCompany.

(l)Good Standing.TheRepresentativesshallhavereceivedonandasoftheClosingDateortheAdditionalClosingDate,asthecasemaybe,satisfactoryevidenceofthegoodstandingoftheCompanyanditssubsidiariesintheirrespectivejurisdictionsoforganizationandtheirgoodstandingasforeignentitiesinsuchotherjurisdictionsastheRepresentativesmayreasonablyrequest,ineachcaseinwritingoranystandardformoftelecommunicationfromtheappropriategovernmentalauthoritiesofsuchjurisdictions.

(m)Exchange Listing.TheSharestobedeliveredontheClosingDateorAdditionalClosingDate,asthecasemaybe,shallhavebeenapprovedforlistingontheNYSE,subjecttoofficialnoticeofissuance.

(n)Lock-up Agreements.The“lock-up”agreements,eachsubstantiallyintheformofExhibitAhereto,betweenyouandeachoftheexecutiveofficersanddirectorsoftheCompanyrelatingtosalesandcertainotherdispositionsofsharesofStockorcertainothersecurities,deliveredtoyouonorbeforethedatehereof,shallbefullforceandeffectontheClosingDateorAdditionalClosingDate,asthecasemaybe.

(o)Chief Financial Officer’s Certificate.OnthedateofthisAgreementandontheClosingDateortheAdditionalClosingDate,asthecasemaybe,theCompanyshallhavefurnishedtotheRepresentativesacertificate,datedtherespectivedatesofdeliverythereofandaddressedtotheUnderwriters,ofitschieffinancialofficerwithrespecttocertainfinancialdatacontainedinthePricingDisclosurePackageandtheProspectus,providing“managementcomfort”withrespecttosuchinformation,informandsubstancereasonablysatisfactorytotheRepresentatives.

(p)Additional Documents.OnorpriortotheClosingDateortheAdditionalClosingDate,asthecasemaybe,theCompanyshallhavefurnishedtotheRepresentativessuchfurthercertificatesanddocumentsastheRepresentativesmayreasonablyrequest.

Allopinions,letters,certificatesandevidencementionedaboveorelsewhereinthisAgreementshallbedeemedtobeincompliancewiththeprovisionshereofonlyiftheyareinformandsubstancereasonablysatisfactorytocounselfortheUnderwriters.

7.IndemnificationandContribution.

(a)Indemnification of the Underwriters.TheCompanyagreestoindemnifyandholdharmlesseachUnderwriter,itsaffiliates,directorsandofficersandeachperson,ifany,whocontrolssuchUnderwriterwithinthemeaningofSection15oftheSecuritiesActorSection20oftheExchangeAct,fromandagainstanyandalllosses,claims,damagesandliabilities(including,withoutlimitation,legalfees

25

andotherreasonableexpensesincurredinconnectionwithanysuit,actionorproceedingoranyclaimasserted,assuchfeesandexpensesareincurred),jointorseveral,thatariseoutof,orarebasedupon,(i)anyuntruestatementorallegeduntruestatementofamaterialfactcontainedinorincorporatedbyreferenceintheRegistrationStatementorcausedbyanyomissionorallegedomissiontostatethereinamaterialfactrequiredtobestatedthereinornecessaryinordertomakethestatementstherein,notmisleading,or(ii)anyuntruestatementorallegeduntruestatementofamaterialfactcontainedinorincorporatedbyreferenceintheProspectus(oranyamendmentorsupplementthereto),anyPreliminaryProspectus,anyIssuerFreeWritingProspectus,any“issuerinformation”filedorrequiredtobefiledpursuanttoRule433(d)undertheSecuritiesAct,anyroadshowasdefinedinRule433(h)undertheSecuritiesAct(a“roadshow”)oranyPricingDisclosurePackage(includinganyPricingDisclosurePackagethathassubsequentlybeenamended),orcausedbyanyomissionorallegedomissiontostatethereinamaterialfactnecessaryinordertomakethestatementstherein,inlightofthecircumstancesunderwhichtheyweremade,notmisleading,ineachcaseexceptinsofarassuchlosses,claims,damagesorliabilitiesariseoutof,orarebasedupon,anyuntruestatementoromissionorallegeduntruestatementoromissionmadeinrelianceuponandinconformitywithanyinformationrelatingtoanyUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforusetherein,itbeingunderstoodandagreedthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsoftheinformationdescribedassuchinsubsection(b)below.

(b)Indemnification of the Company.EachUnderwriteragrees,severallyandnotjointly,toindemnifyandholdharmlesstheCompany,itsdirectors,itsofficerswhosignedtheRegistrationStatementandeachperson,ifany,whocontrolstheCompanywithinthemeaningofSection15oftheSecuritiesActorSection20oftheExchangeActtothesameextentastheindemnitysetforthinparagraph(a)above,butonlywithrespecttoanylosses,claims,damagesorliabilitiesthatariseoutof,orarebasedupon,anyuntruestatementoromissionorallegeduntruestatementoromissionmadeinrelianceuponandinconformitywithanyinformationrelatingtosuchUnderwriterfurnishedtotheCompanyinwritingbysuchUnderwriterthroughtheRepresentativesexpresslyforuseintheRegistrationStatement,theProspectus(oranyamendmentorsupplementthereto),anyPreliminaryProspectus,anyIssuerFreeWritingProspectus,anyroadshoworanyPricingDisclosurePackage(includinganyPricingDisclosurePackagethathassubsequentlybeenamended),itbeingunderstoodandagreeduponthattheonlysuchinformationfurnishedbyanyUnderwriterconsistsofthefollowinginformationintheProspectusfurnishedonbehalfofeachUnderwriter:theconcessionandreallowancefiguresappearinginthethirdparagraphunderthecaption“Underwriting”andtheinformationcontainedinthetwelfthparagraphunderthecaption“Underwriting.

(c)Notice and Procedures.Ifanysuit,action,proceeding(includinganygovernmentalorregulatoryinvestigation),claimordemandshallbebroughtorassertedagainstanypersoninrespectofwhichindemnificationmaybesoughtpursuanttoeitherparagraph(a)or(b)above,suchperson(the“IndemnifiedPerson”)shallpromptlynotifythepersonagainstwhomsuchindemnificationmaybesought(the“IndemnifyingPerson”)inwriting;providedthatthefailuretonotifytheIndemnifyingPersonshallnotrelieveitfromanyliabilitythatitmayhaveunderparagraph(a)or(b)aboveexcepttotheextentthatithasbeenmateriallyprejudiced(throughtheforfeitureofsubstantiverightsordefenses)bysuchfailure;andprovided,further,thatthefailuretonotifytheIndemnifyingPersonshallnotrelieveitfromanyliabilitythatitmayhavetoanIndemnifiedPersonotherwisethanunderparagraph(a)or(b)above.IfanysuchproceedingshallbebroughtorassertedagainstanIndemnifiedPersonanditshallhavenotifiedtheIndemnifyingPersonthereof,theIndemnifyingPersonshallretaincounselreasonablysatisfactorytotheIndemnifiedPerson(whoshallnot,withouttheconsentoftheIndemnifiedPerson,becounseltotheIndemnifyingPerson)torepresenttheIndemnifiedPersonandanyothersentitledtoindemnificationpursuanttothisSectionthattheIndemnifyingPersonmaydesignateinsuchproceedingandshallpaythefeesandexpensesinsuchproceedingandshallpaythefeesandexpensesofsuchcounselrelatedtosuchproceeding,asincurred.In

26

anysuchproceeding,anyIndemnifiedPersonshallhavetherighttoretainitsowncounsel,butthefeesandexpensesofsuchcounselshallbeattheexpenseofsuchIndemnifiedPersonunless(i)theIndemnifyingPersonandtheIndemnifiedPersonshallhavemutuallyagreedtothecontrary;(ii)theIndemnifyingPersonhasfailedwithinareasonabletimetoretaincounselreasonablysatisfactorytotheIndemnifiedPerson;(iii)theIndemnifiedPersonshallhavereasonablyconcludedthattheremaybelegaldefensesavailabletoitthataredifferentfromorinadditiontothoseavailabletotheIndemnifyingPerson;or(iv)thenamedpartiesinanysuchproceeding(includinganyimpleadedparties)includeboththeIndemnifyingPersonandtheIndemnifiedPersonandrepresentationofbothpartiesbythesamecounselwouldbeinappropriateduetoactualorpotentialdifferinginterestsbetweenthem.ItisunderstoodandagreedthattheIndemnifyingPersonshallnot,inconnectionwithanyproceedingorrelatedproceedingsinthesamejurisdiction,beliableforthefeesandexpensesofmorethanoneseparatefirm(inadditiontoanylocalcounsel)forallIndemnifiedPersons,andthatallsuchfeesandexpensesshallbepaidorreimbursedastheyareincurred.AnysuchseparatefirmforanyUnderwriter,itsaffiliates,directorsandofficersandanycontrolpersonsofsuchUnderwritershallbedesignatedinwritingbytheRepresentativesandanysuchseparatefirmfortheCompany,itsdirectors,itsofficerswhosignedtheRegistrationStatementandanycontrolpersonsoftheCompanyshallbedesignatedinwritingbytheCompany.TheIndemnifyingPersonshallnotbeliableforanysettlementofanyproceedingeffectedwithoutitswrittenconsent,butifsettledwithsuchconsentoriftherebeafinaljudgmentfortheplaintiff,theIndemnifyingPersonagreestoindemnifyeachIndemnifiedPersonfromandagainstanylossorliabilitybyreasonofsuchsettlementorjudgment.Notwithstandingtheforegoingsentence,ifatanytimeanIndemnifiedPersonshallhaverequestedthatanIndemnifyingPersonreimbursetheIndemnifiedPersonforfeesandexpensesofcounselascontemplatedbythisparagraph,theIndemnifyingPersonshallbeliableforanysettlementofanyproceedingeffectedwithoutitswrittenconsentif(i)suchsettlementisenteredintomorethan30daysafterreceiptbytheIndemnifyingPersonofsuchrequestand(ii)theIndemnifyingPersonshallnothavereimbursedtheIndemnifiedPersoninaccordancewithsuchrequestpriortothedateofsuchsettlement.NoIndemnifyingPersonshall,withoutthewrittenconsentoftheIndemnifiedPerson,effectanysettlementofanypendingorthreatenedproceedinginrespectofwhichanyIndemnifiedPersonisorcouldhavebeenapartyandindemnificationcouldhavebeensoughthereunderbysuchIndemnifiedPerson,unlesssuchsettlement(x)includesanunconditionalreleaseofsuchIndemnifiedPerson,informandsubstancereasonablysatisfactorytosuchIndemnifiedPerson,fromallliabilityonclaimsthatarethesubjectmatterofsuchproceedingand(y)doesnotincludeanystatementastooranyadmissionoffault,culpabilityorafailuretoactbyoronbehalfofanyIndemnifiedPerson.

(d)Contribution.Iftheindemnificationprovidedforinparagraphs(a)and(b)aboveisunavailabletoanIndemnifiedPersonorinsufficientinrespectofanylosses,claims,damagesorliabilitiesreferredtotherein,theneachIndemnifyingPersonundersuchparagraph,inlieuofindemnifyingsuchIndemnifiedPersonthereunder,shallcontributetotheamountpaidorpayablebysuchIndemnifiedPersonasaresultofsuchlosses,claims,damagesorliabilities(i)insuchproportionasisappropriatetoreflecttherelativebenefitsreceivedbytheCompany,ontheonehand,andtheUnderwritersontheother,fromtheofferingoftheSharesor(ii)iftheallocationprovidedbyclause(i)isnotpermittedbyapplicablelaw,insuchproportionasisappropriatetoreflectnotonlytherelativebenefitsreferredtoinclause(i)butalsotherelativefaultoftheCompany,ontheonehand,andtheUnderwritersontheother,inconnectionwiththestatementsoromissionsthatresultedinsuchlosses,claims,damagesorliabilities,aswellasanyotherrelevantequitableconsiderations.TherelativebenefitsreceivedbytheCompany,ontheonehand,andtheUnderwritersontheother,shallbedeemedtobeinthesamerespectiveproportionsasthenetproceeds(beforedeductingexpenses)receivedbytheCompanyfromthesaleoftheSharesandthetotalunderwritingdiscountsandcommissionsreceivedbytheUnderwritersinconnectiontherewith,ineachcaseassetforthinthetableonthecoveroftheProspectus,beartotheaggregateofferingpriceoftheShares.TherelativefaultoftheCompany,ontheonehand,andtheUnderwritersontheother,shallbedeterminedbyreference

27

to,amongotherthings,whethertheuntrueorallegeduntruestatementofamaterialfactortheomissionorallegedomissiontostateamaterialfactrelatestoinformationsuppliedbytheCompanyorbytheUnderwritersandtheparties’relativeintent,knowledge,accesstoinformationandopportunitytocorrectorpreventsuchstatementoromission.

(e)Limitation on Liability.TheCompanyandtheUnderwritersagreethatitwouldnotbejustandequitableifcontributionpursuanttoparagraph(d)aboveweredeterminedbyprorataallocation(eveniftheUnderwritersweretreatedasoneentityforsuchpurpose)orbyanyothermethodofallocationthatdoesnottakeaccountoftheequitableconsiderationsreferredtoinparagraph(d)above.TheamountpaidorpayablebyanIndemnifiedPersonasaresultofthelosses,claims,damagesandliabilitiesreferredtoinparagraph(d)aboveshallbedeemedtoinclude,subjecttothelimitationssetforthabove,anylegalorotherexpensesincurredbysuchIndemnifiedPersoninconnectionwithanysuchactionorclaim.Notwithstandingtheprovisionsofparagraphs(d)and(e),innoeventshallanUnderwriterberequiredtocontributeanyamountinexcessoftheamountbywhichthetotalunderwritingdiscountsandcommissionsreceivedbysuchUnderwriterwithrespecttotheofferingoftheSharesexceedstheamountofanydamagesthatsuchUnderwriterhasotherwisebeenrequiredtopaybyreasonofsuchuntrueorallegeduntruestatementoromissionorallegedomission.Nopersonguiltyoffraudulentmisrepresentation(withinthemeaningofSection11(f)oftheSecuritiesAct)shallbeentitledtocontributionfromanypersonwhowasnotguiltyofsuchfraudulentmisrepresentation.TheUnderwriters’obligationstocontributepursuanttoparagraphs(d)and(e)areseveralinproportiontotheirrespectivepurchaseobligationshereunderandnotjoint.

(f)Non-Exclusive Remedies.TheremediesprovidedforinthisSection7arenotexclusiveandshallnotlimitanyrightsorremedieswhichmayotherwisebeavailabletoanyIndemnifiedPersonatlaworinequity.

8.EffectivenessofAgreement.ThisAgreementshallbecomeeffectiveupontheexecutionanddeliveryhereofbythepartieshereto.

9.Termination.ThisAgreementmaybeterminatedintheabsolutediscretionoftheRepresentatives,bynoticetotheCompany,ifaftertheexecutionanddeliveryofthisAgreementandpriortotheClosingDateor,inthecaseoftheOptionShares,priortotheAdditionalClosingDate:(i)tradinggenerallyshallhavebeensuspendedormateriallylimitedonorbyanyoftheNYSEorTheNasdaqStockMarket;(ii)tradingofanysecuritiesissuedorguaranteedbytheCompanyshallhavebeensuspendedonanyexchangeorinanyover-the-countermarket;(iii)ageneralmoratoriumoncommercialbankingactivitiesshallhavebeendeclaredbyfederalorNewYorkStateauthorities;or(iv)thereshallhaveoccurredanyoutbreakorescalationofhostilitiesoranychangeinfinancialmarketsoranycalamityorcrisis,eitherwithinoroutsidetheUnitedStates,that,inthejudgmentoftheRepresentatives,ismaterialandadverseandmakesitimpracticableorinadvisabletoproceedwiththeoffering,saleordeliveryoftheSharesontheClosingDateortheAdditionalClosingDate,asthecasemaybe,onthetermsandinthemannercontemplatedbythisAgreement,thePricingDisclosurePackageandtheProspectus.

10.DefaultingUnderwriter.

(a)If,ontheClosingDateortheAdditionalClosingDate,asthecasemaybe,anyUnderwriterdefaultsonitsobligationtopurchasetheSharesthatithasagreedtopurchasehereunderonsuchdate,thenon-defaultingUnderwritersmayintheirdiscretionarrangeforthepurchaseofsuchSharesbyotherpersonssatisfactorytotheCompanyonthetermscontainedinthisAgreement.If,within36hoursafteranysuchdefaultbyanyUnderwriter,thenon-defaultingUnderwritersdonotarrangeforthepurchaseof

28

suchShares,thentheCompanyshallbeentitledtoafurtherperiodof36hourswithinwhichtoprocureotherpersonssatisfactorytothenon-defaultingUnderwriterstopurchasesuchSharesonsuchterms.IfotherpersonsbecomeobligatedoragreetopurchasetheSharesofadefaultingUnderwriter,eitherthenon-defaultingUnderwritersortheCompanymaypostponetheClosingDateortheAdditionalClosingDate,asthecasemaybe,foruptofivefullbusinessdaysinordertoeffectanychangesthatintheopinionofcounselfortheCompanyorcounselfortheUnderwritersmaybenecessaryintheRegistrationStatementandtheProspectusorinanyotherdocumentorarrangement,andtheCompanyagreestopromptlyprepareanyamendmentorsupplementtotheRegistrationStatementandtheProspectusthateffectsanysuchchanges.AsusedinthisAgreement,theterm“Underwriter”includes,forallpurposesofthisAgreementunlessthecontextotherwiserequires,anypersonnotlistedinSchedule1heretothat,pursuanttothisSection10,purchasesSharesthatadefaultingUnderwriteragreedbutfailedtopurchase.

(b)If,aftergivingeffecttoanyarrangementsforthepurchaseoftheSharesofadefaultingUnderwriterorUnderwritersbythenon-defaultingUnderwritersandtheCompanyasprovidedinparagraph(a)above,theaggregatenumberofSharesthatremainunpurchasedontheClosingDateortheAdditionalClosingDate,asthecasemaybe,doesnotexceedone-eleventhoftheaggregatenumberofSharestobepurchasedonsuchdate,thentheCompanyshallhavetherighttorequireeachnon-defaultingUnderwritertopurchasethenumberofSharesthatsuchUnderwriteragreedtopurchasehereunderonsuchdateplussuchUnderwriter’sproratashare(basedonthenumberofSharesthatsuchUnderwriteragreedtopurchaseonsuchdate)oftheSharesofsuchdefaultingUnderwriterorUnderwritersforwhichsucharrangementshavenotbeenmade.

(c)If,aftergivingeffecttoanyarrangementsforthepurchaseoftheSharesofadefaultingUnderwriterorUnderwritersbythenon-defaultingUnderwritersandtheCompanyasprovidedinparagraph(a)above,theaggregatenumberofSharesthatremainunpurchasedontheClosingDateortheAdditionalClosingDate,asthecasemaybe,exceedsone-eleventhoftheaggregateamountofSharestobepurchasedonsuchdate,oriftheCompanyshallnotexercisetherightdescribedinparagraph(b)above,thenthisAgreementor,withrespecttoanyAdditionalClosingDate,theobligationoftheUnderwriterstopurchaseSharesontheAdditionalClosingDateshallterminatewithoutliabilityonthepartofthenon-defaultingUnderwriters.AnyterminationofthisAgreementpursuanttothisSection10shallbewithoutliabilityonthepartoftheCompany,exceptthattheCompanywillcontinuetobeliableforthepaymentofexpensesassetforthinSection11hereofandexceptthattheprovisionsofSection7hereofshallnotterminateandshallremainineffect.

(d)NothingcontainedhereinshallrelieveadefaultingUnderwriterofanyliabilityitmayhavetotheCompanyoranynon-defaultingUnderwriterfordamagescausedbyitsdefault.

11.PaymentofExpenses.

(a)WhetherornotthetransactionscontemplatedbythisAgreementareconsummatedorthisAgreementisterminated,theCompanywillpayorcausetobepaidallcostsandexpensesincidenttotheperformanceofitsobligationshereunder,includingwithoutlimitation,(i)thecostsincidenttotheauthorization,issuance,sale,preparationanddeliveryoftheSharesandanytaxespayableinthatconnection;(ii)thecostsincidenttothepreparation,printingandfilingundertheSecuritiesActoftheRegistrationStatement,thePreliminaryProspectus,anyIssuerFreeWritingProspectus,anyPricingDisclosurePackageandtheProspectus(includingallexhibits,amendmentsandsupplementsthereto)andthedistributionthereof;(iii)thefeesandexpensesoftheCompany’scounselandindependentaccountants;(iv)thereasonablefeesandexpensesincurredinconnectionwiththeregistrationorqualificationanddeterminationofeligibilityforinvestmentoftheSharesunderthestateorforeignsecuritiesorblueskylawsofsuch

29

jurisdictionsastheRepresentativesmaydesignateandthepreparation,printinganddistributionofaBlueSkyMemorandum(includingtherelatedfeesandexpensesofcounselfortheUnderwriters);(v)thecostofpreparingstockcertificates;(vi)thecostsandchargesofanytransferagentandanyregistrar;(vii)allexpensesandapplicationfeesincurredinconnectionwithanyfilingwith,andclearanceoftheofferingby,FINRA(includingtherelatedfeesandexpensesofcounselfortheUnderwriters);and(viii)allexpensesincurredbytheCompanyinconnectionwithany“roadshow”presentationtopotentialinvestors,exceptthatthecostofanyaircraftorothertransportationcharteredinconnectiontherewithshallbesplit50:50withtheUnderwriters;and(ix)allexpensesandapplicationfeesrelatedtothelistingoftheSharesontheNYSE;provided,however,thatthefeesandexpensesofcounselinclauses(iv)and(vii)shallinnoeventexceed$40,000intheaggregate.

(b)If(i)thisAgreementisterminatedpursuanttoSection9,(ii)theCompanyforanyreasonfailstotendertheSharesfordeliverytotheUnderwritersor(iii)theUnderwritersdeclinetopurchasetheSharesforanyreasonpermittedunderthisAgreement,theCompanyagreestoreimbursetheUnderwritersforallout-of-pocketcostsandexpenses(includingthereasonablydocumentedfeesandexpensesoftheircounsel)reasonablyincurredbytheUnderwritersinconnectionwiththisAgreementandtheofferingcontemplatedhereby.Fortheavoidanceofdoubt,itisunderstoodthattheCompanyshallnotpayorreimburseanycosts,feesorexpensesincurredbyanyUnderwriterthatdefaultsonitsobligationstopurchasetheShares.

12.PersonsEntitledtoBenefitofAgreement.ThisAgreementshallinuretothebenefitofandbebindinguponthepartiesheretoandtheirrespectivesuccessorsandtheofficersanddirectorsandanycontrollingpersonsreferredtoinSection7hereof.NothinginthisAgreementisintendedorshallbeconstruedtogiveanyotherpersonanylegalorequitableright,remedyorclaimunderorinrespectofthisAgreementoranyprovisioncontainedherein.NopurchaserofSharesfromanyUnderwritershallbedeemedtobeasuccessormerelybyreasonofsuchpurchase.

13.Survival.Therespectiveindemnities,rightsofcontribution,representations,warrantiesandagreementsoftheCompanyandtheUnderwriterscontainedinthisAgreementormadebyoronbehalfoftheCompanyortheUnderwriterspursuanttothisAgreementoranycertificatedeliveredpursuantheretoshallsurvivethedeliveryofandpaymentfortheSharesandshallremaininfullforceandeffect,regardlessofanyterminationofthisAgreementoranyinvestigationmadebyoronbehalfoftheCompanyortheUnderwriters.

14.CertainDefinedTerms.ForpurposesofthisAgreement,(a)exceptwhereotherwiseexpresslyprovided,theterm“affiliate”hasthemeaningsetforthinRule405undertheSecuritiesAct;(b)theterm“businessday”meansanydayotherthanadayonwhichbanksarepermittedorrequiredtobeclosedinNewYorkCity;(c)theterm“subsidiary”hasthemeaningsetforthinRule405undertheSecuritiesAct;and(d)theterm“significantsubsidiary”hasthemeaningsetforthinRule1-02ofRegulationS-XundertheExchangeAct.IntheeventthattheCompanyhasonlyonesubsidiary,thenallreferenceshereinto“subsidiaries”oftheCompanyshallbedeemedtorefertosuchsinglesubsidiary,mutatismutandis.

15.CompliancewithUSAPatriotAct.InaccordancewiththerequirementsoftheUSAPatriotAct(TitleIIIofPub.L.107-56(signedintolawOctober26,2001)),theUnderwritersarerequiredtoobtain,verifyandrecordinformationthatidentifiestheirrespectiveclients,includingtheCompany,whichinformationmayincludethenameandaddressoftheirrespectiveclients,aswellasotherinformationthatwillallowtheUnderwriterstoproperlyidentifytheirrespectiveclients.

30

16.Miscellaneous.

(a)Authority of the Representatives.AnyactionbytheUnderwritershereundermaybetakenbytheRepresentativesonbehalfoftheUnderwriters,andanysuchactiontakenbytheRepresentativesshallbebindingupontheUnderwriters.

(b)Notices.Allnoticesandothercommunicationshereundershallbeinwritingandshallbedeemedtohavebeendulygivenifmailedortransmittedandconfirmedbyanystandardformoftelecommunication.NoticestotheUnderwritersshallbegiventotheRepresentativesc/oJ.P.MorganSecuritiesLLC,383MadisonAvenue,NewYork,NewYork10179(fax:(212)622-8358);AttentionEquitySyndicateDesk;andc/oCowenandCompany,LLC,Attention:HeadofEquityCapitalMarkets(fax:(646)562-1249),withacopytotheGeneralCounsel(fax:(646)562-1124).NoticestotheCompanyshallbegiventoitatInvitaeCorporation,140016thStreet,SanFrancisco,California94103,(fax:(415)276-4164);Attention:GeneralCounsel.

(c)Submission to Jurisdiction.TheCompanyherebysubmitstotheexclusivejurisdictionoftheU.S.federalandNewYorkstatecourtsintheBoroughofManhattaninTheCityofNewYorkinanysuitorproceedingarisingoutoforrelatingtothisAgreementorthetransactionscontemplatedhereby.TheCompanywaivesanyobjectionwhichitmaynoworhereafterhavetothelayingofvenueofanysuchsuitorproceedinginsuchcourts.TheCompanyagreesthatfinaljudgmentinanysuchsuit,actionorproceedingbroughtinsuchcourtshallbeconclusiveandbindingupontheCompanyandmaybeenforcedinanycourttothejurisdictionofwhichCompanyissubjectbyasuituponsuchjudgment.

(d)Governing Law.ThisAgreementandanyclaim,controversyordisputearisingunderorrelatedtothisAgreementshallbegovernedbyandconstruedinaccordancewiththelawsoftheStateofNewYorkapplicabletoagreementsmadeandtobeperformedinsuchstate.

(e)Waiver of Jury Trial.TheCompanyherebyirrevocablywaives,tothefullestextentpermittedbyapplicablelaw,anyandallrighttotrialbyjuryinanylegalproceedingarisingoutoforrelatingtothisAgreementorthetransactionscontemplatedhereby.

(f)Recognition of the U.S. Special Resolution Regimes.

(i)IntheeventthatanyUnderwriterthatisaCoveredEntitybecomessubjecttoaproceedingunderaU.S.SpecialResolutionRegime,thetransferfromsuchUnderwriterofthisAgreement,andanyinterestandobligationinorunderthisAgreement,willbeeffectivetothesameextentasthetransferwouldbeeffectiveundertheU.S.SpecialResolutionRegimeifthisAgreement,andanysuchinterestandobligation,weregovernedbythelawsoftheUnitedStatesorastateoftheUnitedStates.

(ii)IntheeventthatanyUnderwriterthatisaCoveredEntityoraBHCActAffiliateofsuchUnderwriterbecomessubjecttoaproceedingunderaU.S.SpecialResolutionRegime,DefaultRightsunderthisAgreementthatmaybeexercisedagainstsuchUnderwriterarepermittedtobeexercisedtonogreaterextentthansuchDefaultRightscouldbeexercisedundertheU.S.SpecialResolutionRegimeifthisAgreementweregovernedbythelawsoftheUnitedStatesorastateoftheUnitedStates.

31

AsusedinthisSection16(g):

“BHCActAffiliate”hasthemeaningassignedtotheterm“affiliate”in,andshallbeinterpretedinaccordancewith,12U.S.C.§1841(k).

“CoveredEntity”meansanyofthefollowing:

(i)a“coveredentity”asthattermisdefinedin,andinterpretedinaccordancewith,12C.F.R.§252.82(b);

(ii)a“coveredbank”asthattermisdefinedin,andinterpretedinaccordancewith,12C.F.R.§47.3(b);or

(iii)a“coveredFSI”asthattermisdefinedin,andinterpretedinaccordancewith,12C.F.R.§382.2(b).

“DefaultRight”hasthemeaningassignedtothattermin,andshallbeinterpretedinaccordancewith,12C.F.R.§§252.81,47.2or382.1,asapplicable.

“U.S.SpecialResolutionRegime”meanseachof(i)theFederalDepositInsuranceActandtheregulationspromulgatedthereunderand(ii)TitleIIoftheDodd-FrankWallStreetReformandConsumerProtectionActandtheregulationspromulgatedthereunder.

(g)Counterparts.ThisAgreementmaybesignedincounterparts(whichmayincludecounterpartsdeliveredbyanystandardformoftelecommunication),eachofwhichshallbeanoriginalandallofwhichtogethershallconstituteoneandthesameinstrument.

(h)Amendments or Waivers.NoamendmentorwaiverofanyprovisionofthisAgreement,noranyconsentorapprovaltoanydeparturetherefrom,shallinanyeventbeeffectiveunlessthesameshallbeinwritingandsignedbythepartieshereto.

(i)Headings.Theheadingshereinareincludedforconvenienceofreferenceonlyandarenotintendedtobepartof,ortoaffectthemeaningorinterpretationof,thisAgreement.

(j)Integration. ThisAgreementsupersedesallprioragreementsandunderstandings(whetherwrittenororal)betweentheCompanyandtheUnderwriters,oranyofthem,withrespecttothesubjectmatterhereof.

[signature page follows]

32

Iftheforegoingisinaccordancewithyourunderstanding,pleaseindicateyouracceptanceofthisAgreementbysigninginthespaceprovidedbelow.

Verytrulyyours,

INVITAECORPORATION

By: /s/SeanE.GeorgeName:SeanE.GeorgeTitle:PresidentandChiefExecutiveOfficer

Accepted:Asofthedatefirstwrittenabove

J.P.MORGANSECURITIESLLCCOWENANDCOMPANY,LLC

ForthemselvesandonbehalfoftheseveralUnderwriterslistedinSchedule1hereto.J.P.MORGANSECURITIESLLC

By: /s/BenjaminBurdett AuthorizedSignatory

COWENANDCOMPANY,LLC

By: /s/E.JamesStreator,III AuthorizedSignatory

Schedule1

Underwriter NumberofShares

J.P.MorganSecuritiesLLC 10,666,667CowenandCompany,LLC 7,111,111

Total 17,777,778

Schedule2

SignificantSubsidiaries

CombiMatrixCorporation,aDelawarecorporationClearGenetics,Inc.,aDelawarecorporationJungla,LLC,aDelawarelimitedliabilitycompanySingularBio,Inc.,aDelawarecorporation

AnnexAa. Pricing Disclosure Package

None.

b. Pricing Information Provided Orally by Underwriters

Pricepersharetothepublic:$9.00

NumberofsharesbeingsoldbytheCompany:17,777,778

Numberofsharespotentiallyissuablepursuanttotheoptiontopurchaseadditionalshares:2,666,666

AnnexB

PricingTermSheet

None.

ExhibitA

FORMOFLOCK-UPAGREEMENT

,2020

J.P.MORGANSECURITIESLLCCOWENANDCOMPANY,LLC

AsRepresentativesoftheseveralUnderwriterslistedinSchedule1totheUnderwritingAgreementreferredtobelow

c/oJ.P.MorganSecuritiesLLC383MadisonAvenueNewYork,NY10179

c/oCowenandCompany,LLC599LexingtonAvenueNewYork,NY10022

Re:InvitaeCorporation—PublicOffering

LadiesandGentlemen:

Theundersignedunderstandsthatyou,asrepresentatives(the“Representatives”)oftheseveralUnderwriters,proposetoenterintoanUnderwritingAgreement(the“UnderwritingAgreement”)withInvitaeCorporation,aDelawarecorporation(the“Company”),providingforthepublicoffering(the“PublicOffering”)bytheseveralUnderwritersnamedinSchedule1totheUnderwritingAgreement(the“Underwriters”),ofcommonstock,parvalue$0.0001pershare(“CommonStock”),oftheCompany(the“Securities”).CapitalizedtermsusedhereinandnototherwisedefinedshallhavethemeaningssetforthintheUnderwritingAgreement.

InconsiderationoftheUnderwriters’agreementtopurchaseandmakethePublicOfferingoftheSecurities,andforothergoodandvaluableconsiderationreceiptofwhichisherebyacknowledged,theundersignedherebyagreesthat,withoutthepriorwrittenconsentofJ.P.MorganSecuritiesLLConbehalfoftheUnderwriters,theundersignedwillnot,andwillnotcauseanydirectorindirectaffiliateto,duringtheperiodcommencingonthedatehereofandendingatthecloseofbusiness60days(the“Lock-upPeriod”)afterthedateoftheprospectussupplementrelatingtothePublicOffering(the“Prospectus”),(1)lend,offer,pledge,sell,contracttosell,sellanyoptionorcontracttopurchase,purchaseanyoptionorcontracttosell,grantanyoption,rightorwarranttopurchase,orotherwisetransferordisposeof,directlyorindirectly,anysharesofCommonStockoranysecuritiesconvertibleintoorexercisableorexchangeableforCommonStock(including,withoutlimitation,CommonStockorsuchothersecuritieswhichmaybedeemedtobebeneficiallyownedbytheundersignedinaccordancewiththerulesandregulationsoftheSecuritiesandExchangeCommissionandsecuritieswhichmaybeissueduponexerciseofastockoptionorwarrant)(the“OtherSecurities”andtogetherwiththeCommonStock,the“LockupSecurities”),(2)enterintoanyhedging,swaporotheragreementthattransfers,inwholeorinpart,anyof

theeconomicconsequencesofownershipoftheCommonStockorsuchOtherSecurities,whetheranysuchtransactiondescribedinclause(1)or(2)aboveistobesettledbydeliveryofCommonStockorsuchOtherSecurities,incashorotherwise,(3)makeanydemandfororexerciseanyrightwithrespecttotheregistrationofanysharesofCommonStockoranysecurityconvertibleintoorexercisableorexchangeableforCommonStock,or(4)publiclydisclosetheintentiontodoanyoftheforegoing(and,fortheavoidanceofdoubt,theundersignedherebywaivesanyandallnoticerequirementsandrightswithrespecttotheregistrationofanysecuritiespursuanttoanyagreement,instrument,understandingorotherwise,includinganystockholdersorregistrationrightsagreementorsimilaragreement,towhichtheundersignedisapartyorunderwhichtheundersignedisentitledtoanyrightorbenefit),ineachcaseotherthan(A)transfersofsharesofCommonStockasabonafidegiftorgifts,(B)distributionsofsharesofCommonStocktomembersorstockholdersoftheundersigned,(C)broker-assistedsaleor“net”exerciseofoutstandingoptionstopurchasesharesofCommonStockorsettlementofrestrictedstockunitsinaccordancewiththeirtermspursuanttoanemployeebenefitplan,ineachcasesolelytocoveranytaxwithholdingobligationsdueasaresultofsuchexerciseorsettlement,uptoacombinedaggregateof150,000sharesofCommonStockforalldirectorsandexecutiveofficerswhohavesignedalockupagreementinconnectionwiththePublicOffering,provided,further,thatanyfilingundertheExchangeAct(asdefinedbelow)withregardtothisclause(C)shallclearlyindicateinthefootnotestheretothatthefilingrelatestothecircumstancesdescribedinthisclause(C),andnootherpublicannouncementshallberequiredorshallbemadevoluntarilyinconnectionwithsuchexercise,[and](D)establishingatradingplanpursuanttoRule10b5-1undertheSecuritiesExchangeActof1934,asamended(the“ExchangeAct”)forthetransferofCommonStock(a“TradingPlan”);providedthatsuchplandoesnotprovideforanytransfersofCommonStockduringtheLock-upPeriod[and(E)thetransferofsharesofCommonStockunderaTradingPlanthatisexistingonthedatehereofwhichhasbeenprovidedtotheRepresentativesoritslegalcounsel;provided,that,totheextentapublicannouncementorfilingundertheExchangeAct,ifany,isrequiredoforvoluntarilymadebyoronbehalfoftheundersignedortheCompanyregardingsuchtransfer,suchannouncementorfilingshallincludeastatementthatsuchtransferisinaccordancewithanestablishedTradingPlan]1;provided,thatinthecaseofanytransferordistributionpursuanttoclause(A)or(B),eachdoneeordistributeeshallexecuteanddelivertotheRepresentativesalock-upletterintheformofthisparagraph;andprovided,further,thatinthecaseofanytransferordistributionpursuanttoclause(A),(B)or(D),nofilingbyanyparty(donor,donee,transferorortransferee)undertheExchangeAct,orotherpublicannouncementshallberequiredorshallbemadevoluntarilyinconnectionwithsuchtransferordistribution(otherthanafilingonaForm5madeaftertheexpirationoftheLock-upPeriod).

Theundersignedacknowledgesandagreesthattheforegoingprecludestheundersignedfromengaginginanyhedgingorothertransactionsorarrangements(including,withoutlimitation,anyshortsaleorthepurchaseorsaleof,orentryinto,anyputorcalloption,orcombinationthereof,forward,swaporanyotherderivativetransactionorinstrument,howeverdescribedordefined)designedorintended,orwhichcouldreasonablybeexpectedtoleadtoorresultin,asaleordisposition(whetherbytheundersignedorsomeoneotherthantheundersigned)ortransferofanyeconomicconsequencesofownership,inwholeorinpart,directlyorindirectly,ofanysharesofLockupSecurities,whetheranysuchtransactionorarrangement(orinstrumentprovidedforthereunder)wouldbesettledbydeliveryofCommonStockorOtherSecurities,incashorotherwise.TheundersignedfurtherconfirmsthatithasfurnishedtheRepresentativeswiththedetailsofanytransactiontheundersigned,oranyofitsaffiliates,isapartytoasofthedatehereof,whichtransactionwouldhavebeenrestrictedbythisletteragreementifithadbeenenteredintobytheundersignedduringtheLock-upPeriod.1 Toincludeforpeoplewithtradingplanscurrentlyinplace.

Iftheundersignedisnotanaturalperson,theundersignedrepresentsandwarrantsthatnosinglenaturalperson,entityor“group”(withinthemeaningofSection13(d)(3)oftheExchangeAct),otherthananaturalperson,entityor“group”(asdescribedabove)thathasexecutedaletteragreementinsubstantiallythesameformasthisletteragreement,beneficiallyowns,directlyorindirectly,50%ormoreofthecommonequityinterests,or50%ormoreofthevotingpower,intheundersigned.

Infurtheranceoftheforegoing,theCompany,andanydulyappointedtransferagentfortheregistrationortransferofthesecuritiesdescribedherein,areherebyauthorizedtodeclinetomakeanytransferofsecuritiesifsuchtransferwouldconstituteaviolationorbreachofthisletteragreement.

Theundersignedherebyrepresentsandwarrantsthattheundersignedhasfullpowerandauthoritytoenterintothisletteragreement.Allauthorityhereinconferredoragreedtobeconferredandanyobligationsoftheundersignedshallbebindinguponthesuccessors,assigns,heirsorpersonalrepresentativesoftheundersigned.

Theundersignedshallbereleasedfromallobligationsunderthisletteragreementif:(i)theUnderwritingAgreementdoesnotbecomeeffectivebyApril30,2020;(ii)iftheUnderwritingAgreement(otherthantheprovisionsthereofwhichsurvivetermination)shallterminateorbeterminatedpriortopaymentforanddeliveryoftheCommonStocktobesoldthereunder;or(iii)priortotheexecutionoftheUnderwritingAgreement,theCompanynotifiestheRepresentativesinwritingthatitdoesnotintendtoproceedwiththePublicOffering.TheundersignedunderstandsthattheUnderwritersareenteringintotheUnderwritingAgreementandproceedingwiththePublicOfferinginrelianceuponthisletteragreement.

[Signature Page Follows]

Thisletteragreementandanyclaim,controversyordisputearisingunderorrelatedtothisletteragreementshallbegovernedbyandconstruedinaccordancewiththelawsoftheStateofNewYork,withoutregardtotheconflictoflawsprinciplesthereof.

Verytrulyyours,

NameofSecurityHolder(Print exact name)

By: Signature

Ifnotsigninginanindividualcapacity:

NameofAuthorizedSignatory(Print)

TitleofAuthorizedSignatory(Print)

(indicate capacity of person signing if signing as custodian,trustee, or on behalf of an entity)

[Signature Page to Lockup Agreement]

Exhibit 5.1

PILLSBURYWINTHROPSHAWPITTMANLLP2550HanoverStreetPaloAlto,CA94304

April6,2020

InvitaeCorporation140016thStreetSanFrancisco,CA94103

LadiesandGentlemen:

WehaveactedascounselforInvitaeCorporation,aDelawarecorporation(the“Company”),inconnectionwiththeissuanceandsaleof20,444,444shares(the“Shares”)ofcommonstock,$0.0001parvaluepershare(the“CommonStock”),oftheCompany,allofwhichareauthorizedbutheretoforeunissuedsharestobeofferedandsoldbytheCompany,pursuanttotheRegistrationStatementonFormS-3(RegistrationNo.333-230053)(the“RegistrationStatement”),filedbytheCompanywiththeSecuritiesandExchangeCommission(the“Commission”)undertheSecuritiesActof1933(the“Act”),andrelatedprospectus,datedMarch4,2019,assupplementedbytheprospectussupplementdatedApril1,2020relatingtotheofferandsaleoftheShares(assosupplemented,the“Prospectus”).

Wehavereviewedandarefamiliarwithsuchdocuments,corporateproceedingsandothermattersaswehaveconsideredrelevantornecessaryasabasisfortheopinionsexpressedinthisletter.Onthebasisoftheforegoingandsubjecttotheotherqualificationsandlimitationssetforthherein,weareoftheopinionthattheShareshavebeendulyauthorizedand,whenissuedandsoldbytheCompanyinthemannerdescribedintheRegistrationStatementandtheProspectusandinaccordancewiththeresolutionsadoptedbytheBoardofDirectorsoftheCompany,willbevalidlyissued,fullypaidandnonassessable.

TheopinionssetforthinthisletterarelimitedtotheGeneralCorporationLawoftheStateofDelaware,asineffectonthedatehereof.

WeherebyconsenttothefilingofthisopinionletterasExhibit5.1totheCompany’sCurrentReportonForm8-KfiledbytheCompanywiththeCommissiononthedatehereofandtheincorporationthereofintheRegistrationStatementandtotheuseofournameunderthecaption“LegalMatters”intheProspectus.Ingivingthisconsent,wedonottherebyadmitthatwearewithinthecategoryofpersonswhoseconsentisrequiredunderSection7oftheActortherulesandregulationsoftheCommissionpromulgatedthereunder.

Verytrulyyours,

/s/PillsburyWinthropShawPittmanLLP

Exhibit 99.1

Invitae Announces Pricing of Public Offering of Common Stock

SANFRANCISCO,April1,2020—InvitaeCorporation(NYSE:NVTA)todayannouncedthepricingofanunderwrittenpublicofferingof17,777,778sharesofitscommonstockatapricetothepublicof$9.00pershare.AllofthesharesarebeingsoldbyInvitae.ThegrossproceedstoInvitaefromtheoffering,beforedeductingtheunderwritingdiscountsandcommissionsandotherofferingexpenses,areexpectedtobeapproximately$160.0million.TheofferingisexpectedtocloseonoraboutApril6,2020,subjecttocustomaryclosingconditions.Inaddition,Invitaehasgrantedtheunderwritersa30-dayoptiontopurchaseuptoanadditional2,666,666sharesofitscommonstockatthepublicofferingprice,lessunderwritingdiscountsandcommissions.

J.P.MorganSecuritiesLLCandCowenandCompany,LLCareactingasthebook-runningmanagersfortheoffering.

AnautomaticshelfregistrationstatementrelatingtotheshareswasfiledwiththeSecuritiesandExchangeCommissionandbecameeffectiveonMarch4,2019.Acopyofthefinalprospectussupplementandaccompanyingprospectusrelatingtotheoffering,whenavailable,maybeobtainedfromJ.P.MorganSecuritiesLLC,c/oBroadridgeFinancialSolutions,1155LongIslandAvenue,Edgewood,NY11717,orbytelephoneat(866)803-9204,orbyemailatprospectus-eq_fi@jpmchase.com;orfromCowenandCompany,LLC,c/oBroadridgeFinancialSolutions,1155LongIslandAvenue,Edgewood,NY11717,Attn:ProspectusDepartment,byemailatPostSaleManualRequests@broadridge.comorbytelephoneat(833)297-2926.

Thispressreleaseshallnotconstituteanoffertosellorthesolicitationofanoffertobuythesesecurities,norshalltherebeanysaleofthesesecuritiesinanystateorjurisdictioninwhichsuchoffer,solicitationorsalewouldbeunlawfulpriortoregistrationorqualificationunderthesecuritieslawsofanysuchstateorjurisdiction.

About Invitae Corporation

InvitaeCorporation(NYSE:NVTA)isaleadingmedicalgeneticscompany,whosemissionistobringcomprehensivegeneticinformationintomainstreammedicinetoimprovehealthcareforbillionsofpeople.Invitae’sgoalistoaggregatetheworld’sgenetictestsintoasingleservicewithhigherquality,fasterturnaroundtime,andlowerprices.

Forward-Looking Statements

Thispressreleasecontainsforward-lookingstatementswithinthePrivateSecuritiesLitigationReformActof1995,includingstatementsthatrelatetotheoffering,theexpectedclosingoftheofferingandotherinformationthatisnothistoricalinformation.Actualresultsordevelopmentsmaydiffermateriallyfromthoseprojectedorimpliedintheseforward-lookingstatements.Factorsthatmaycausesuchadifferenceincluderisksanduncertaintiesrelatedtocompletionofthepublicofferingontheanticipatedtermsoratall,marketconditionsandthesatisfactionofcustomaryclosingconditionsrelatedtothepublicoffering.MoreinformationabouttherisksanduncertaintiesfacedbyInvitaeiscontainedinthesectioncaptioned“Riskfactors”inthepreliminaryprospectussupplementrelatedtothepublicofferingfiledwiththeSecuritiesandExchangeCommission.Invitaedisclaimsanyintentionorobligationtoupdateorreviseanyforward-lookingstatements,whetherasaresultofnewinformation,futureeventsorotherwise.

Source:InvitaeCorporation

Contact:LauraD’Angeloir@invitae.com(628)213-3369

Exhibit 99.2

Invitae Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stockand Closing of Underwritten Public Offering

SANFRANCISCO,April6,2020—InvitaeCorporation(NYSE:NVTA)todayannouncedtheclosingofitsunderwrittenpublicofferingof20,444,444sharesofitscommonstock,including2,666,666sharessoldpursuanttotheexerciseinfulloftheunderwriters’optiontopurchaseadditionalshares,atthepublicofferingpriceof$9.00pershare.Asaresultoftheunderwriters’optionexercise,theaggregategrossproceedstoInvitaefromtheoffering,beforedeductingunderwritingdiscountsandcommissionsandotherofferingexpenses,wasapproximately$184.0million.

J.P.MorganSecuritiesLLCandCowenandCompany,LLCactedasthebook-runningmanagersfortheoffering.

AnautomaticshelfregistrationstatementrelatingtotheshareswasfiledwiththeSecuritiesandExchangeCommissionandbecameeffectiveonMarch4,2019.AcopyofthefinalprospectussupplementandaccompanyingprospectusrelatingtotheofferingmaybeobtainedfromJ.P.MorganSecuritiesLLC,c/oBroadridgeFinancialSolutions,1155LongIslandAvenue,Edgewood,NY11717,orbytelephoneat(866)803-9204,orbyemailatprospectus-eq_fi@jpmchase.com;orfromCowenandCompany,LLC,c/oBroadridgeFinancialSolutions,1155LongIslandAvenue,Edgewood,NY11717,Attn:ProspectusDepartment,byemailatPostSaleManualRequests@broadridge.comorbytelephoneat(833)297-2926.

Thispressreleaseshallnotconstituteanoffertosellorthesolicitationofanoffertobuythesesecurities,norshalltherebeanysaleofthesesecuritiesinanystateorjurisdictioninwhichsuchoffer,solicitationorsalewouldbeunlawfulpriortoregistrationorqualificationunderthesecuritieslawsofanysuchstateorjurisdiction.

About Invitae Corporation

InvitaeCorporation(NYSE:NVTA)isaleadingmedicalgeneticscompany,whosemissionistobringcomprehensivegeneticinformationintomainstreammedicinetoimprovehealthcareforbillionsofpeople.Invitae’sgoalistoaggregatetheworld’sgenetictestsintoasingleservicewithhigherquality,fasterturnaroundtime,andlowerprices.

Source:InvitaeCorporation

Contact:LauraD’Angeloir@invitae.com(628)213-3369